Methods and systems for separating components of a biological sample with gravity sedimentation

ABSTRACT

Aspects of the present disclosure include methods for separating components having different densities from a biological sample droplet. Methods according to certain embodiments include contacting a surface of a support with a biological sample droplet that includes components of different densities; subjecting the biological sample droplet to a gravitational force to produce two or more regions in the biological sample droplet on the support surface, where each region in the biological sample droplet includes a component from the biological sample droplet having a different density; separating the biological sample droplet into two or more product droplets, wherein each product droplet includes a different region of the biological sample droplet; and collecting the one or more product droplets. Systems for practicing the subject methods are also described. Computer systems and kits are also provided.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims priority to U.S. Provisional Patent ApplicationSer. No. 62/031,753, filed on Jul. 31, 2014, the disclosure of which isincorporated herein by reference.

INTRODUCTION

Components (e.g., cells) from biological fluids are used in numeroustherapeutic, diagnostic and research applications. For example, bloodtests often require separation of white blood cells, red blood cells andplasma components. Providing enriched and enhanced preparations of thebiological samples, having sufficient concentration for desiredtherapeutic, diagnostic or research use, can often require numerous andlengthy manipulations. These manipulations can diminish the amount ofseparated biological material recovered. For example, centrifugation ofsamples can result in losses because each separated phase of thebiological sample cannot be fully recovered. In some cases, multipleiterations of separation, washing and other types of treatments can bedeleterious to components of the biological sample causing losses incomponent viability due to over-processing. Still further, large amountsof the biological fluid may not be readily available. In some cases,only a few microliters of the biological fluid can be made available,making a reduction in processing losses highly impactful.

Isolating and enriching components of a biological sample can vary indegree of selectivity, speed and convenience and can depend not only onthe approach and conditions used but also on the geometricconfigurations of the extraction. There is a constant need for thedevelopment of simplified and miniaturized sample preparation methodsrequiring lower quantities of materials and more efficient ways toobtain isolated and enriched biological samples. Methods and systemsthat provide improved separation of components of biological samples onsmall samples with little to no loss are of interest.

SUMMARY

Aspects of the present disclosure include methods for separatingcomponents having different densities in a biological sample droplet.Methods according to certain embodiments include contacting a surface ofa support with a biological sample droplet that includes components ofdifferent densities; subjecting the biological sample droplet to agravitational force to produce two or more regions in the biologicalsample droplet on the support surface, where each region in thebiological sample droplet includes a component from the biologicalsample droplet having a different density; separating the biologicalsample droplet into two or more product droplets, where each productdroplet includes a different region of the biological sample droplet;and collecting one or more of the product droplets. Methods, in certaininstances also include conveying one or more product droplets along thesupport surface by applying an electric field to discrete regions of thesupport. In some embodiment, methods further include washing the productdroplets by contacting the product droplet with a wash buffer to producea washed droplet; subjecting the washed droplet to a gravitational forcesufficient to produce two or more regions in the washed droplet on thesupport surface, where each region in the washed droplet includes acomponent having a different density; separating the washed droplet intotwo or more separated washed product droplets, where each separatedwashed product droplet includes a different region of the washeddroplet; and collecting one or more of the separated washed productdroplets.

Systems, including a support configured to separate a biological sampledroplet into two or more distinct product droplets and an actuator forpositioning the support in a manner sufficient to subject the biologicalsample droplet to a gravitational force suitable for practicing thesubject methods are also described.

BRIEF DESCRIPTION OF THE FIGURES

The invention may be best understood from the following detaileddescription when read in conjunction with the accompanying drawings.Included in the drawings are the following figures:

FIG. 1A depicts a schematic showing the separation of a biologicalsample droplet into two separated droplets according to certainembodiments.

FIG. 1B depicts a schematic showing the separation of an array ofbiological sample droplets on a support, each biological sample dropletbeing separated into two distinct droplets according to certainembodiments.

FIGS. 2A-C illustrate configurations for positioning the supportaccording to certain embodiments. FIG. 2A shows a side view of a supportpositioned on a platform positioned at an angle with respect to a planeparallel to the ground. FIG. 2B shows a side view of a supportpositioned on a platform at a 45° angle with respect to a plane parallelto the ground. FIG. 2C shows a side view of a support position on aplatform at a 90° angle with respect to a plane parallel to the ground.

FIG. 3 depicts a step-wise schematic showing a separation protocol of anarray of biological sample droplets on a support according to certainembodiments.

FIG. 4 depicts a step-wise schematic showing a separation protocol of anarray of biological sample droplets on a support according to certainother embodiments.

DETAILED DESCRIPTION

Before the present invention is described in greater detail, it is to beunderstood that this invention is not limited to particular embodimentsdescribed, as such may vary. It is also to be understood that theterminology used herein is for the purpose of describing particularembodiments only, and is not intended to be limiting, since the scope ofthe present invention will be limited only by the appended claims.

Where a range of values is provided, it is understood that eachintervening value, to the tenth of the unit of the lower limit unlessthe context clearly dictates otherwise, between the upper and lowerlimit of that range and any other stated or intervening value in thatstated range, is encompassed within the invention. The upper and lowerlimits of these smaller ranges may independently be included in thesmaller ranges and are also encompassed within the invention, subject toany specifically excluded limit in the stated range. Where the statedrange includes one or both of the limits, ranges excluding either orboth of those included limits are also included in the invention.

Unless defined otherwise, all technical and scientific terms used hereinhave the same meaning as commonly understood by one of ordinary skill inthe art to which this invention belongs. Although any methods andmaterials similar or equivalent to those described herein can also beused in the practice or testing of the present invention, representativeillustrative methods and materials are now described.

All publications and patents cited in this specification are hereinincorporated by reference as if each individual publication or patentwere specifically and individually indicated to be incorporated byreference and are incorporated herein by reference to disclose anddescribe the methods and/or materials in connection with which thepublications are cited. The citation of any publication is for itsdisclosure prior to the filing date and should not be construed as anadmission that the present invention is not entitled to antedate suchpublication by virtue of prior invention. Further, the dates ofpublication provided may be different from the actual publication dateswhich may need to be independently confirmed.

It is noted that, as used herein and in the appended claims, thesingular forms “a”, “an”, and “the” include plural referents unless thecontext clearly dictates otherwise. It is further noted that the claimsmay be drafted to exclude any optional element. As such, this statementis intended to serve as antecedent basis for use of such exclusiveterminology as “solely,” “only” and the like in connection with therecitation of claim elements, or use of a “negative” limitation.

As will be apparent to those of skill in the art upon reading thisdisclosure, each of the individual embodiments described and illustratedherein has discrete components and features which may be readilyseparated from or combined with the features of any of the other severalembodiments without departing from the scope or spirit of the presentinvention. Any recited method can be carried out in the order of eventsrecited or in any other order which is logically possible.

As summarized above, the present disclosure provides methods forseparating components having different densities from a biologicalsample droplet. In further describing embodiments of the disclosure,methods for separating components in a biological sample droplet arefirst described in greater detail. Next, systems suitable for practicingthe subject methods are described. Computer systems and kits are alsoprovided.

Methods for Separating Components from a Biological Sample Droplet byGravity Sedimentation

As summarized above, aspects of the present disclosure include methodsfor separating components of a biological sample droplet by subjectingthe biological sample droplet to a gravitational force. The term“separating” is used herein in its conventional sense to refer to thephysical separation of a plurality of components based on a particularphysical or chemical property such as density of the component. Asdescribed in greater detail below, the biological sample droplet issubjected to a gravitational force for a duration sufficient to separatecomponents of the biological sample droplet into two or more regions,each region containing components of different density. In embodiments,components are separated within the biological sample droplet such thateach component has a higher concentration in a particular region (e.g.,bottom region, upper region, middle region, etc.) as compared tocomponents in a biological sample droplet not subjected to thegravitational force. In other words, components of a biological sampledroplet are separated in a manner sufficient to enrich components intoparticular regions of the biological sample droplet.

For example, the concentration of a component in a particular region ofthe biological sample droplet (e.g., bottom region, upper region, middleregion, etc.) may be increased by 5% or more, such as by 10% or more,such as by 20% or more, such as by 25% or more, such as by 30% or more,such as by 50% or more, such as by 75% or more, such as 90% including by95% or more. In some instances, the concentration of a component in aparticular region of the biological sample droplet may be increased by2-fold or more, such as by 3-fold or more, such as by 5-fold or more,such as by 7-fold or more and including by 10-fold or more.

In embodiments of the present disclosure, components of the biologicalsample droplet may be separated into two or more regions such that 5% ormore of a certain component is separated in a particular region (e.g.,bottom region, upper region, middle region, etc.) of the biologicalsample droplet, such as 10% or more, such as 20% or more, such as 25% ormore, such as 30% or more, such as 40% or more, such as 50% or more,such as 60% or more, such as 70% or more, such as 80% or more, such as90% or more, such as 95% or more and including separating 99% or more ofa component into a particular region of the biological sample droplet.In certain embodiments, 100% of the component is separated into aparticular region of the biological sample droplet.

For instance, in one example, the biological sample includes twocomponents and the biological sample droplet is subjected to agravitational force for a duration sufficient to separate 95% or more ofa first component into a first region (e.g., bottom region) of thebiological sample droplet and 95% or more of the second component into asecond region (e.g., upper region) of the biological sample droplet. Inthis example, 5% or less of the first component is present in the secondregion (e.g, upper region) and 5% or less of the second component ispresent in the first region (e.g., bottom region) after subjecting thebiological sample droplet to the gravitational force.

In another example, the biological sample droplet includes twocomponents and the biological sample droplet is subjected to agravitational force for a duration sufficient to separate 100% or moreof a first component into a first region (e.g., bottom region) of thebiological sample droplet and 95% or more of the second component into asecond region (e.g., upper region) of the biological sample droplet. Inthis example, none of the first component is present in the secondregion (e.g., upper region) and 5% or less of the second component ispresent in the first region (e.g., bottom region) after subjecting thebiological sample droplet to the gravitational force.

In yet another example, the biological sample droplet includes threecomponents and is subjected to a gravitational force for a durationsufficient to separate 95% or more of a first component into a firstregion of the biological sample droplet and 95% or more of a secondcomponent and a third component into a second region. In this example,5% or less of the first component is present in the second region and 5%or less of the second and third components are present in the firstregion after subjecting the biological sample droplet to thegravitational force.

In yet another example, the biological sample droplet includes threecomponents and is subjected to a gravitational force for a durationsufficient to separate 95% or more of a first component into a firstregion of the biological sample droplet and 100% or more of a secondcomponent and a third component into a second region. In this example,5% or less of the first component is present in the second region andnone of the second and third components are present in the first regionafter subjecting the biological sample droplet to the gravitationalforce.

In still another example, the biological sample droplet includes twocomponents and is subjected to a gravitational force for a durationsufficient to separate 100% of the first component into a first regionof the biological sample and 100% of the second component into a secondregion. In this example, none of the first component is present in thesecond region and none of the second component is present in the firstregion after subjecting the biological sample droplet to thegravitational force.

In certain embodiments, the biological sample droplet is a whole blooddroplet and the whole blood droplet is subjected to a gravitationalforce for a duration sufficient to separate 5% or more of the red bloodcells and white blood cells into a first region of the whole blooddroplet (e.g., bottom region), such as 10% or more, such as 25% or more,such as 30% or more, such as 40% or more, such as 50% or more, such as60% or more, such as 70% or more, such as 80% or more, such as 90% ormore, such as 95% or more and including isolating 99% or more of the redblood cells and white blood cells into a first region of the whole blooddroplet. In some instances, methods include subjecting the whole blooddroplet to a gravitational force for a duration sufficient to separate100% of the red blood cells and white blood cells into a first region ofthe whole blood droplet. In these embodiments, the whole blood dropletis subjected to a gravitational force for a duration sufficient toseparate 5% or more of the blood plasma into a second region (e.g.,upper region) of the whole blood droplet, such as 10% or more, such as25% or more, such as 30% or more, such as 40% or more, such as 50% ormore, such as 60% or more, such as 70% or more, such as 80% or more,such as 90% or more, such as 95% or more and including isolating 99% ormore of the blood plasma into a second region (e.g., upper region) ofthe whole blood droplet.

For example, in some instances the whole blood droplet is subjected to agravitational force for a duration sufficient to separate 95% or more ofthe red blood cells and white blood cells into a first region (e.g.,bottom region) of the whole blood droplet and 95% or more of the bloodplasma into a second region (e.g., upper region). In these instances, 5%or less of the blood plasma is present in the first region (e.g., bottomregion) and 5% or less of the red blood cells and white blood cells arepresent in the second region (e.g., upper region) after subjecting thewhole blood droplet to the gravitational force.

In other instances, the whole blood droplet is subjected to agravitational force for a duration sufficient to separate 100% or moreof the red blood cells and white blood cells into a first region (e.g.,bottom region) of the whole blood droplet and 95% or more of the bloodplasma into a second region (e.g., upper region). In these instances,none of the red blood cells and white blood cells are present in thesecond region (e.g., upper region) and 5% or less of the blood plasma ispresent in the first region (e.g., bottom region) after subjecting thewhole blood droplet to the gravitational force.

In certain instances, 100% of the red blood cells and white blood cellsare separated into a first region (e.g., bottom region) and 100% of theplasma is separated into a second region (e.g., upper region) aftersubjecting the whole blood droplet to the gravitational force.

As used herein, the term “biological sample” is used in its conventionalsense to refer to a subset of plant, fungi, bacteria or animal tissues,cells or component parts which may in certain instances be found inblood, mucus, lymphatic fluid, synovial fluid, cerebrospinal fluid,saliva, bronchoalveolar lavage, amniotic fluid, amniotic cord blood,urine, vaginal fluid and semen. As such, a “biological sample” may referto both the native organism or a subset of its tissues as well as to ahomogenate, lysate or extract prepared from the organism or a subset ofits tissues, including but not limited to, for example, plasma, serum,spinal fluid, lymph fluid, sections of the skin, respiratory,gastrointestinal, cardiovascular, and genitourinary tracts, tears,saliva, milk, blood cells, tumors, organs. Biological samples may be anytype of organismic tissue, including both healthy and diseased tissue(e.g., cancerous, malignant, necrotic, etc.) In certain embodiments, thebiological sample contains cells. Suitable cells include eukaryoticcells (e.g., mammalian cells) and/or prokaryotic cells (e.g., bacterialcells or archaeal cells). Samples may be obtained from an in vitrosource (e.g., a suspension of cells from laboratory cells grown inculture) or from an in vivo source (e.g., a mammalian subject, a humansubject, etc.). In some embodiments, the cellular sample is obtainedfrom an in vitro source. In vitro sources include, but are not limitedto, prokaryotic (e.g., bacterial, archaeal) cell cultures, environmentalsamples that contain prokaryotic and/or eukaryotic (e.g., mammalian,protest, fungal, etc.) cells, eukaryotic cell cultures (e.g., culturesof established cell lines, cultures of known or purchased cell lines,cultures of immortalized cell lines, cultures of primary cells, culturesof laboratory yeast, etc.), tissue cultures, and the like.

In some embodiments, the sample is obtained from an in vivo source andcan include samples obtained from tissues (e.g., cell suspension from atissue biopsy, cell suspension from a tissue sample, etc.) and/or bodyfluids (e.g., whole blood, fractionated blood, plasma, serum, saliva,lymphatic fluid, interstitial fluid, etc.). In some cases, cells,fluids, or tissues derived from a subject are cultured, stored, ormanipulated prior to evaluation. In vivo sources include livingmulti-cellular organisms and can yield non-diagnostic or diagnosticcellular samples.

In certain embodiments the source of the sample is a “mammal” or“mammalian”, where these terms are used broadly to describe organismswhich are within the class mammalia, including the orders carnivore(e.g., dogs and cats), rodentia (e.g., mice, guinea pigs, and rats), andprimates (e.g., humans, chimpanzees, and monkeys). In some instances,the subjects are humans. The methods may be applied to samples obtainedfrom human subjects of both genders and at any stage of development(i.e., neonates, infant, juvenile, adolescent, adult), where in certainembodiments the human subject is a juvenile, adolescent or adult. Whilethe present invention may be applied to samples from a human subject, itis to be understood that the methods may also be carried-out on samplesfrom other animal subjects (that is, in “non-human subjects”) such as,but not limited to, birds, mice, rats, dogs, cats, livestock and horses.

Methods according to embodiments of the present disclosure separate oneor more components of the biological sample droplet into distinctproduct droplets and may include separating cells from other types ofcells, separating cells from non-cellular debris (e.g., cell fragments,fragmented cell membranes, organelles, dead or lysed cells), separatingcells from non-cellular macromolecules such as free lipids, proteins,polysaccharides and nucleic acid fragments as well as separating onetype of non-cellular macromolecules from other types non-cellularmacromolecules. In some embodiments, the subject methods separate cellsfrom non-cellular components of a biological sample. In otherembodiments, the subject methods separate two or more different types ofcells from each other. In yet other embodiments, the subject methodsseparate two or more different types of non-cellular components (e.g.,polysaccharides and proteins) from each other. In certain embodiments,the biological sample is whole blood and the subject methods separatewhite blood cells and red blood cells from plasma. In still otherembodiments, the biological sample is whole blood and the subjectmethods separate white blood cells from red blood cells.

As summarized above, components in a biological sample droplet havingdifferent densities are separated from each other by subjecting thebiological sample droplet to a gravitational force. Upon subjecting thebiological sample droplet to a gravitational force, components of higherdensity separate from components of lower density within the biologicalsample droplet. After subjecting the biological sample droplet to thegravitational force for a sufficient duration, two or more distinctregions are formed in the biological sample droplet where each regionincludes components of different densities. For example, a biologicalsample droplet containing a high density component and a low densitycomponent is subjected to a gravitational force sufficient to producewithin the biological sample droplet a region with the high densitycomponent and a region with the lower density component. As described ingreater detail below, a droplet dividing force, such as an electricfield applied in an electrowetting protocol, may be applied to thesupport in a manner sufficient to divide the biological sample dropletinto two distinct product droplets on the support. Each product dropletmay include one or more components of the biological sample droplet,such as two or more components, such as three or more components andincluding five or more components, as described below.

FIG. 1A depicts a schematic showing the separation of a biologicalsample droplet into two separated droplets by subjecting the biologicalsample droplet to a gravitational force according to embodiments of thepresent disclosure. At step 1 of FIG. 1A, biological sample droplet 101contacted with support 100 contains components 102 a and 102 b havingdifferent densities homogeneously distributed within the biologicalsample droplet. Subjecting biological sample droplet 101 to agravitational force 110 a at step 2 causes component 102 a, which has ahigher density, to settle at the bottom of the droplet (i.e., in thedirection of the gravitational force) more than component 102 b. Aftersubjecting the biological sample droplet to the gravitational force 110a for a sufficient duration, the components of the biological sampledroplet separate into two regions in the biological sample droplet, eachregion having components of different density. Here, higher densitycomponents 102 a separate into the lower region of the biological sampledroplet and lower density components 102 b remain in the upper region ofthe biological sample droplet. (Step 2) Application of a dropletdividing force 110 c, such as an electric field applied in aneletrowetting protocol causes the biological sample droplet (step 3) toform a pre-separated droplet p103 which begins to divide the biologicalsample droplet into two product droplets where a first product dropletcontains higher density components 102 a and a second product dropletcontains lower density components 102 b. After application of dividingforce 110 c for a sufficient duration (step 4), product droplet 103containing higher density component 102 a and product droplet 101containing lower density component 102 b become completely separatedfrom each other. In this embodiment, product droplet 103 retains highdensity component 102 a, while product droplet 101 retains lower densitycomponent 102 b.

FIG. 1B depicts a schematic showing the separation of an array ofbiological sample droplets on a support, each biological sample dropletbeing separated into two distinct droplets according to embodiments ofthe present disclosure. At step 1 of FIG. 1B, biological sample droplets101 b are contacted with support 100 b. Each biological sample droplet101 b contains components 102 a and 102 b having different densitieshomogeneously distributed within the biological sample droplet.Subjecting the array of biological sample droplets to a gravitationalforce 110 b at step 2 causes higher density components 102 a to beginsettling to the bottom of the biological sample droplet. Aftersubjecting the biological sample droplet to the gravitational force fora sufficient duration, the components of each biological sample dropletseparate into two regions in the biological sample droplet, each regionhaving components of different density. Here, higher density components102 a separate into the lower region of each biological sample dropletand lower density components 102 b remain in the upper region of eachbiological sample droplet. Application of a droplet dividing force 110d, such as an electric field applied in an eletrowetting protocol,causes each biological sample droplet to form pre-separated dropletsp103 b which begins to divide the region containing higher densitycomponents 102 a from the region containing lower density components 102b. After application of dividing force 110 d for a sufficient duration,fully separated product droplets 103 b are formed from each of thepre-separated droplets p103 b (step 3). As discussed above, separatedproduct droplets 103 b contain higher density components 102 a whilelower density components 102 b are retained in product droplets 101 b.

In embodiments, the biological sample droplet is divided into one ormore distinct droplets having components of higher density and one ormore distinct droplets having components of lower density. By “distinct”and “separated” is meant that the separated product droplets are not influid communication with each other. In other words, there is at leastsome void space between the separated product droplets (i.e., a space orregion on the support where no liquid is present). In embodiments,depending on the droplet dividing force employed to divide thebiological sample droplet into the product droplets as well as theproperties of the biological sample (e.g., fluid viscosity, cellular andnon-cellular composition), the distance between each separated dropletmay vary, where distinct droplets may be separated by a distance of0.001 mm or more, such as by 0.005 mm or more, such as by 0.01 mm ormore, such as by 0.05 mm or more, such as 0.1 mm or more, such as by 0.5mm or more, such as by 1 mm or more, such as by 5 mm or more andincluding by 10 mm or more.

When separated, each distinct product droplet may include one or morecomponents of interest from the biological sample droplet, such as twoor more components of interest, such as three or more components ofinterest, such as 4 or more components of interest and including 5 ormore components of interest. For example, where the biological sampledroplet includes 4 components having different densities and isseparated into two distinct product droplets (i.e., a separated dropletand the remaining portion of the biological sample droplet), a firstseparated product droplet may include 1 component and a second separatedproduct droplet may include the 3 other components. In otherembodiments, a first separated product droplet may include 2 componentsand a second separated product droplet may include the other 2components. In still other embodiments, a first separated productdroplet may include 3 components and a second separated product dropletmay include the remaining 1 component. For example, where the biologicalsample droplet is whole blood, a first separated product droplet mayinclude red blood cells and a second separated product droplet mayinclude white blood cells and plasma. In other instances, a firstseparated product droplet may include white blood cells and red bloodcells and a second separated product droplet may include plasma.

As described above, the biological sample droplet is subjected to agravitational force for a duration sufficient to separate components ofdifferent density into two or more regions within the biological sampledroplet. (e.g., higher density components in a bottom region of thebiological sample droplet and lower density components in an upperregion of the biological sample droplet) For example, the biologicalsample droplet may be subjected to a gravitational force for a durationsufficient to separate components of the biological sample by densityinto three different regions within the biological sample droplet ormore, such as four different regions or more and including fivedifferent regions or more. In one instance, the biological sampleincludes two components of interest having different density and methodsinclude subjecting the biological sample droplet to a gravitationalforce for a duration sufficient to separate the two components ofinterest by density into two regions within the biological sampledroplet. In another instance, the biological sample droplet includesthree components of interest having different densities and methodsinclude subjecting the biological sample droplet to a gravitationalforce for a duration sufficient to separate the three components bydensity into two different regions within the biological sample droplet.In yet another instance, the biological sample droplet includes threecomponents of interest having different densities and methods includesubjecting the biological sample droplet to a gravitational force for aduration sufficient to separate the three components by density intothree different regions within the biological sample droplet. In stillother instances, the biological sample droplet includes four componentsof interest having different densities and methods include subjectingthe biological sample droplet to a gravitational force for a durationsufficient to separate the four components by density into two differentregions within the biological sample droplet (e.g., two higher densitycomponents in a bottom region of the biological sample droplet and twolower density components in an upper region of the biological sampledroplet; or one higher density component in a bottom region of thebiological sample droplet and three lower density components in an upperregion of the biological sample droplet)

In some embodiments, the biological sample droplet is a biologicalsample containing cells and methods of the present disclosure includeseparating cellular components and non-cellular components of thebiological sample droplet into two or more regions within the biologicalsample droplet. For example, the biological sample droplet is subjectedto a gravitational force for a duration sufficient to separate cellularcomponents from non-cellular components into two different regionswithin the biological sample droplet. (e.g., cellular components in abottom region of the biological sample droplet and non-cellularcomponents in an upper region of the biological sample droplet)

In other embodiments, the biological sample droplet is a biologicalsample droplet containing two or more different types of cells andmethods include separating each type of cell by density into differentregions within the biological sample droplet. For example, in certaininstances, the biological sample droplet is a whole blood droplet andmethods include separating red blood cells and white blood cells intoone region within the biological sample droplet and plasma into a secondregion within the biological sample droplet (e.g., red blood cells andwhite blood cells in a bottom region of the whole blood droplet andplasma in an upper region of the whole blood droplet) In otherinstances, the biological sample droplet includes red blood cells andwhite blood cells and methods include subjecting the biological sampledroplet to a gravitational force sufficient to separate the red bloodcells into a first region within the biological sample droplet and thewhite blood cells into a second region within the biological sampledroplet.

After subjecting the biological sample droplet to a gravitational forcesufficient to separate components of different densities into two ormore regions in the biological sample droplet, the biological sampledroplet is divided into two or more product droplets, where each productdroplet includes a different region of the biological sample droplet.(e.g., dividing a biological sample droplet having two regions into twoproduct droplets) The biological sample droplet may be divided into twomore product droplets by any convenient droplet dividing protocol, asdescribed in greater detail below, such as for example applying anelectric field in an electrowetting protocol. Depending on the number ofcomponents of interest and regions produced by the applied gravitationalforce, the biological sample droplet may be divided into two or moreproduct droplets, such as three or more product droplets, such as fouror more product droplets and include five or more product droplets.

In some embodiments, the biological sample is a biological samplecontaining cells and methods of the present disclosure include dividingthe biological sample droplet into two or more separated productdroplets, where one or more of the product droplets contain cells andone or more of the product droplets contain non-cellular components. Inother embodiments, the biological sample contains two or more differenttypes of cells and methods include dividing the biological sampledroplet such that each type of cell is divided into distinct productdroplets. For example, in certain instances, the biological sampledroplet is a whole blood droplet and methods of the present disclosureinclude dividing the whole blood droplet into a first product dropletcontaining the cellular components (e.g., red blood cells and whiteblood cells) and a second product droplet containing plasma. In otherembodiments, the whole blood droplet is divided into three productdroplets, white blood cells being in a first product droplet, red bloodcells in a second product droplet and plasma being in a third productdroplet.

In practicing methods of the present disclosure, a biological sampledroplet having components of different densities is contacted with asurface of a support and is subjected to a gravitational force for aduration sufficient to separate the components of different density intotwo or more regions within the biological sample droplet. (e.g., higherdensity components in a bottom region of the biological sample dropletand lower density components in an upper region of the biological sampledroplet). The biological sample droplet is then divided using a dropletdividing protocol into two or more separated product droplets where eachproduct droplet includes one or more regions of the biological sampledroplet.

In some embodiments, the biological sample droplet is directly appliedto the surface of the support, such as with a pipette, needle with orwithout a syringe, a manual or mechanical dropper or acomputer-automated dropper. In other embodiments, the biological sampledroplet is applied to a peripheral position on the support and isconveyed to the desired location on the support by an electrowettingmicroactuation protocol (as described in greater detail below).

In embodiments, the volume of the biological sample droplet applied tothe support surface may vary, for example, ranging in some instancesfrom 0.01 μL to 1000 μL, such as from 0.05 μL to 900 μL, such as from0.1 μL to 800 μL, such as from 0.5 μL to 700 μL, such as from 1 μL to600 μL, such as from 2.5 μL to 500 μL, such as from 5 μL to 400 μL, suchas from 7.5 μL to 300 μL and including from 10 μL to 200 μL of sample.One or more biological sample droplets may be contacted with the supportsurface, such as 2 or more biological sample droplets, such as 3 ormore, such as 5 or more, such as 10 or more and including contacting 15or more biological sample droplets with the support surface. Dependingon the size of the support surface, the applied biological sampledroplets may be spaced apart from each other by 0.1 mm or more, such asby 0.5 mm or more, such as by 1 mm or more, such as by 2 mm or more,such as by 5 mm or more and including by 10 mm or more. The areaoccupied by each sample droplet will vary, depending on the volume ofsample applied and may range from 0.01 to 5 mm², such as 0.05 to 5 mm²,such as 0.1 to 4.5 mm², such as 0.25 to 4.5 mm², such as 0.5 to 4 mm²and including 1 to 4 mm².

The size of each applied droplet may be the same or different or somepercentage therebetween, as desired. In some embodiments, the size ofeach applied droplet is the same. In other embodiments, the size of eachapplied droplet is different and may be selected from a range of dropletsizes. For example, droplets may be applied to the surface in 1 to 10different sizes, such as 2 to 9 different sizes, such as 3 to 8different sizes and including 4 to 6 different sizes. Where a range ofdifferent droplet sizes are applied to the substrate surface, thepercentage of each size of droplet applied to the support surface mayvary, where each size constitutes 5% or more of the droplets, such as10% or more, such as 25% or more, such as 50% or more, such as 75% ormore and including 90% or more of the droplets. In still otherembodiments, every droplet size applied to the support surface isdifferent. Where the size of the applied droplets are different, thesize of the applied droplets on the support may vary by 1% or more, suchas by 5% or more, such as by 10% or more, such as by 15% or more, suchas by 25% or more, such as by 35% or more, such as by 50% or more, suchas by 75% or more, such as by 90% or more and including by 95% or more.

In certain embodiments, each biological sample droplet is contacted witha discrete region on the support surface. As described in greater detailbelow, each discrete region may include one or more electrodesconfigured for conveying a fluidic droplet along the surface of thesupport using an electrowetting microactuation protocol. In someembodiments, each discrete region includes one or more sensors. In theseembodiments, the sensors may be configured for determining the presenceof a fluidic droplet in the discrete region. In other embodiments,sensors of interest may be configured for determining one or morephysical or chemical properties of the droplet positioned in thediscrete region. In certain embodiments, a single biological sampledroplet is applied in each discrete region.

The biological sample droplets may be applied at any convenient positionon the support surface. In some embodiments, the droplets are applied tothe support surface in a random pattern. In other embodiments, thedroplets are applied in a non-random pattern (i.e., in a predeterminedpattern), including in a line pattern or in the pattern of a specificshape (circle, square, triangle, etc.), letter or number configuration.For example, the droplets may be applied to the support surface in agrid pattern.

In practicing the subject methods, the applied biological sample dropletis subjected to a gravitational force. By “gravitational force” is meantan attractive force which acts upon a compound having mass, whereresultant movement is in a direction toward the source of thegravitational force. In certain embodiments, the gravitational force isgravity exerted by the Earth and the direction of force exerted on thebiological sample droplet is in a direction substantially perpendicularto a plane parallel to the surface of the ground.

In some embodiments, the biological sample droplet is subjected to agravitational force immediately after the biological sample droplet iscontacted with the support. In other embodiments, the biological sampledroplet is subjected to the gravitational force a predetermined periodof time after contacting with the support. For example, the biologicalsample droplet may be subjected to a gravitational force 0.01 minutes ormore after contacting with the support, such as after 0.05 minutes ormore, such as after 0.1 minutes or more, such as after 0.5 minutes ormore, such as after 1 minute or more, such as after 5 minutes or more,such as after 10 minutes or more, such as after 15 minutes or more, suchas after 30 minutes or more and including subjecting the biologicalsample droplet to a gravitational force 60 minutes after contacting thebiological sample droplet with the support.

In some embodiments, methods include a storage or prefabrication stepwhere the biological sample droplet is a specimen that has beenpreloaded onto the support surface and is stored on the support for apredetermined period of time before subjecting the biological sampledroplet to the gravitational force. The amount of time the biologicalsample droplet is preloaded and stored on the support surface may vary,such as 0.1 hours or more, such as 0.5 hours or more, such as 1 hour ormore, such as 2 hours or more, such as 4 hours or more, such as 8 hoursor more, such as 16 hours or more, such as 24 hours or more, such as 48hours or more, such as 72 hours or more, such as 96 hours or more, suchas 120 hours or more, such as 144 hours or more, such as 168 hours ormore and including preloading the biological sample droplet onto thesupport surface 240 hours or more before subjecting the biologicalsample droplet to a gravitational force. For example, the amount of timethe biological sample droplet is preloaded and stored on the supportsurface may range from 0.1 hours to 240 hours before subjecting thebiological sample droplet to a gravitational force, such as from 0.5hours to 216 hours, such as from 1 hour to 192 hours and includingpreloading the biological sample droplet onto the support surface from 5hours to 168 hours before subjecting the biological sample droplet to agravitational force. For instance, the biological sample may bepreloaded onto a support surface at a remote location (e.g., using in aphysician's office or outpatient clinic) and sent to a laboratory forprocessing in accordance with the subject methods. By “remote location”is meant a location other than the location at which the sample isobtained and preloaded onto the support surface. For example, a remotelocation could be another location (e.g. office, lab, etc.) in the samecity, another location in a different city, another location in adifferent state, another location in a different country, etc., relativeto the location of the processing device, e.g., as described in greaterdetail below. In some instances, two locations are remote from oneanother if they are separated from each other by a distance of 10 m ormore, such as 50 m or more, including 100 m or more, e.g., 500 m ormore, 1000 m or more, 10,000 m or more, etc.

In some embodiments, subjecting the biological sample droplet to agravitational force includes positioning and maintaining the support atan angle with respect to a plane parallel to the surface of the ground.In these embodiments, gravity exerted by the Earth separates componentsof different density in the biological sample droplet into two or moreregions in the biological sample droplet. Depending on the density ofthe components of the biological sample and the size of biologicalsample droplet, the angle at which the support is positioned may vary,such as for example, positioning the support at an angle that is 5° orgreater with respect to a plane parallel to the surface of the ground,such as at an angle that is 10° or greater, such as at an angle that is15° or greater, such as at an angle that is 25° or greater, such as atan angle that is 35° or greater, such as at an angle that is 45° orgreater, such as at an angle that is 60° or greater, such as at an anglethat is 75° or greater, such as at an angle that is 80° or greater andincluding maintaining the support at an angle that is 90° with respectto a plane parallel to the surface of the ground. In certainembodiments, the support is positioned at an angle that is 45° orgreater with respect to a plane parallel to the surface of the ground.In other embodiments, the support is positioned at an angle that is 90°with respect to a plane parallel to the surface of the ground (i.e.,directly in line with the direction of the gravitational force). In someinstances, the support is positioned at an angle ranging from 5° to 90°with respect to a plane parallel to the surface of the ground, such asat angle from 10° to 85°, such as from 15° to 80°, such as from 20° to75°, such as from 25° to 70°, such as from 35° to 65° and including 40°to 60 with respect to a plane parallel to the surface of the ground.

Schematic diagrams in FIGS. 2A-C illustrate configurations forpositioning the support according to certain embodiments of the presentdisclosure. FIG. 2A depicts a side view of a support 201 a that ispositioned on support platform 202 a at an angle with respect to a planeparallel to the ground 203 a. Support 201 a can be positioned at anangle 204 a which can be varied from 0° to 90° depending on the type ofsample and desired separation within the droplets, as discussed above.Biological sample droplets 205 a and 205 b positioned on the surface ofsupport 201 a are subjected to a gravitational force in the direction210 a for a duration sufficient to separate the components by densitywithin the droplets. FIG. 2B depicts a side view of support 201 bpositioned on support platform 202 b at an angle of 45° with respect toa plane parallel to the ground 203 b. FIG. 2C depicts a side view ofsupport 201 c positioned on support platform 202 c at an angle of 90°with respect to a plane parallel to the ground 203 c.

The biological sample droplet is subjected to a gravitational force fora duration sufficient to separate components of different density intotwo or more regions within the biological sample droplet. Inembodiments, the duration the biological sample droplet is subjected tothe gravitational force may vary and may be 0.01 minutes or longer, suchas for 0.05 minutes or longer, such as for 0.1 minutes or longer, suchas for 0.5 minutes or longer, such as for 1 minute or longer, such asfor 3 minutes or longer, such as for 5 minutes or longer, such as for 10minutes or longer, such as for 15 minutes or longer, such as for 20minutes or longer, such as for 30 minutes or longer, such as for 45minutes or longer, such as for 60 minutes or longer and including for 90minutes or longer. For example, the biological sample droplet may besubjected to the gravitational force for a duration which ranges from0.01 minutes to 960 minutes, such as from 0.05 minutes to 480 minutes,such as from 0.1 minutes to 240 minutes, such as from 0.5 minutes to 120minutes, such as from 1 minute to 90 minutes, such as from 5 minutes to60 minutes and including subjecting the biological sample droplet to thegravitational force for a duration of from 10 minutes to 45 minutes.

The support may be maintained at a single angle or may be changed to adifferent angle at any time during separation of the biological sampledroplets. Where the support is positioned at more than one angle, theduration the support is maintained at each angle may independently be0.01 minutes or more, such as 0.1 minutes or more, such as 1 minute ormore, such as 5 minutes or more, such as 10 minutes or more, such as 30minutes or more and including 60 minutes or more. The time periodbetween each different angle employed may also vary, as desired, beingseparated independently by a delay of 1 minute or more, such as 5minutes or more, such as by 10 minutes or more, such as by 15 minutes ormore, such as by 30 minutes or more and including by 60 minutes or more.In embodiments where the support is maintained at more than two (i.e.,three or more) angles to subject the biological sample droplet to thegravitational force, the delay between each angle employed may be thesame or different.

Depending on the type and number of components of different density inthe biological sample the support may be maintained at an angle tosubject the biological sample droplet to a gravitational forcecontinuously or in discrete intervals. For example, in some embodiments,the support is maintained at an angle to subject the biological sampledroplet to a gravitational force continuously. In other instances, thesupport is maintained at an angle to subject the biological sampledroplet to a gravitational force in discrete intervals, such as forexample for intervals of for 0.01 minutes or longer, such as for 0.05minutes or longer, such as for 0.1 minutes or longer, such as for 0.5minutes or longer, such as for 1 minute or longer, such as for 3 minutesor longer, such as for 5 minutes or longer, such as for 10 minutes orlonger, such as for 15 minutes or longer, such as for 20 minutes orlonger, such as for 30 minutes or longer, such as for 45 minutes orlonger, such as for 60 minutes or longer and including for 90 minutes orlonger. Where the support is maintained at an angle in discreteintervals, methods may include 1 or more intervals, such as 2 or moreintervals, such as 3 or more intervals and including 5 or moreintervals.

In embodiments of the present disclosure, each step (application of thebiological sample droplet to the support, subjecting the biologicalsample droplet to a gravitational force, dividing the biological sampledroplet into two or more separated product droplets and collecting oneor more of the separated product droplets) can be carried out at anysuitable temperature so long as the viability of the components of thebiological sample droplet and separated droplets are preserved asdesired. As such, the temperature according to embodiments of thedisclosure may vary, such as from −80° C. to 100° C., such as from −75°C. to 75° C., such as from −50° C. to 50° C., such as from −25° C. to25° C., such as from −10° C. to 10° C., and including from 0° C. to 25°C. As components of the biological sample droplets are separated by agravitational force into discrete regions within the biological sampledroplet, the amount of time required for separation may depend on theviscosity of the biological fluid sample. For example, the viscosity ofbiological fluid samples separated in accordance with the subjectmethods may range in some aspects from about 0.01 cP to about 750 cP,including about 0.1 cP to about 100 cP, such as about 0.1 cP to 50 cP,about 0.2 cP to about 10 cP, about 0.2 cP to about 2.0 cP, about 0.5 to1.5 cP, or about 0.75 cP to 1.5 cP. In some instances, the viscosity ofthe biological fluid sample has a viscosity substantially equal to thatof water at the given temperature (e.g., about 1 cP at 20° C., about0.65 cP at 40° C.).

In some embodiments, methods further include agitating the support.Agitation may include, but is not limited to applying ultrasound to thebiological sample droplet on the support, shaking the support eithermanually (i.e., by hand) or mechanically (i.e., by a mechanically orelectrically powered shaking device), among other agitating protocols.Depending on the properties of the biological sample droplet (e.g.,viscosity, cellular components) as well as the angle at which thesupport is maintained, the support may be agitated for any amount oftime, such as for one second or longer, such as for two seconds orlonger, such as for 5 seconds or longer, such as for 10 seconds orlonger, such as for 30 seconds or longer, such as for 1 minute orlonger, such as for 5 minutes or longer, such as for 10 minutes orlonger and including agitating the support for 30 minutes or longer. Incertain embodiments, the support is agitated while being positioned atat angle to subject the biological sample droplet to a gravitationalforce.

Where necessary, the parameters for subjecting droplets of interest to agravitational force may be changed at any time during methods of thepresent disclosure. For example, the positioning angle of the support,the duration the droplet is subjected to the gravitational force,heating or cooling of the sample and agitation frequency and durationmay be changed one or more times during the subject methods, such as twoor more times, such as three or more times and including five or moretimes.

In some embodiments, the positioning angle of the support with respectto a plane parallel to the ground may be changed. For example, thepositioning angle of the support may be increased or decreased by 1° ormore, such as by 3° or more, such as by 5° or more, such as by 8° ormore, such as by 10° or more and increasing or decreasing thepositioning angle of the support by 15° or more.

In other embodiments, the duration the biological sample droplet issubjected to the gravitational force may be changed. For example, theduration the biological sample droplet is subjected to the gravitationalforce may be increased or decrease by 0.01 minutes or longer, such as by0.05 minutes or longer, such as by 0.1 minutes or longer, such as by 0.5minutes or longer, such as by 1 minute or longer, such as by 3 minutesor longer, such as by 5 minutes or longer, such as by 10 minutes orlonger, such as by 15 minutes or longer, such as by 20 minutes orlonger, such as by 30 minutes or longer, such as by 45 minutes orlonger, such as by 60 minutes or longer and including by 90 minutes orlonger.

In yet other embodiments, the temperature while subjecting thebiological sample to the gravitational force may be changed. Forexample, the temperature may be raised or lower by 0.1° C. or more, suchas by 0.5° C. or more, such as by 1° C. or more, such as by 2° C. ormore, such as by 5° C. or more and including raising or lowering thetemperature by 8° C. or more.

In certain embodiments, methods include monitoring the biological sampledroplet while separating components of different density into the two ormore regions within the biological sample droplet. Monitoring separationmay include assessing (either by a human or with the assistance of acomputer, if using a computer-automated process initially set up underhuman direction) the extent of component separation within thebiological sample droplet. For example, monitoring separation ofcomponents by density into the two or more regions within the biologicalsample droplet may include determining by optical absorbance theboundary between a region within the biological sample dropletcontaining plasma and a region containing cells. Monitoring separationof components into regions within the biological sample droplet mayinclude assessing the physical and chemical properties of the componentsin each region within the biological sample droplet. Any convenientprotocol can be employed to monitor the biological sample droplet,including but not limited to optical absorption, laser scatter,fluorescence, phosphorescence, chemiluminescence, diffuse reflectance,electrochemical sensing, infrared spectroscopy, among other sensingprotocols.

In some instances, monitoring includes collecting real-time data, suchas employing a detector (e.g., laser scatter detector, opticalabsorption detector, electrochemical sensor). In other instances,monitoring includes assessing the biological sample droplet at regularintervals, such as every 0.01 minutes, every 0.05 minutes, every 0.1minutes, every 0.5 minutes, every 1 minute, every 5 minutes, every 10minutes, every 30 minutes, every 60 minutes or some other interval.

Methods of the present disclosure may also include a step of assessingthe biological sample droplet to identify any desired adjustments to thesubject protocol. In other words, methods in these embodiments includeproviding feedback based on monitoring the biological sample droplet,where adjustments to the protocol may vary in terms of goal, where insome instances the desired adjustment are adjustments that ultimatelyresult in an improved separation of components by density within thebiological sample droplet, such as providing faster separation, improvedpurity or increased component enrichment of the components into the twoor more regions within the biological sample droplets.

Where feedback provided indicates that a particular protocol is lessthan optimal, such as where component separation into regions within thebiological sample droplet requires too much time or where componentseparation provides separated regions within the biological sampledroplet with insufficient enrichment (e.g., components of differentdensity are undesirably mixed together in a region of the biologicalsample droplet), methods may include changing one or more parts of thesubject protocols. For example, one or more parameters for subjectingthe biological sample droplet to a gravitational force may be adjusted.In one example, methods include adjusting the positioning angle of thesupport (as described above). In another example, methods includechanging (increasing or decreasing) the duration the biological sampledroplet is subjected to the gravitational force. In yet another example,methods include heating or cooling the biological sample droplet. Instill another example, methods include implementing or increasing themagnitude of agitation to the biological sample droplet while subjectingthe droplet to the gravitational force.

For instance, where the duration required to separate components ofdifferent density into separated regions within the biological sampledroplet is less than optimal (e.g., longer than desired), methods mayinclude increasing the magnitude of the gravitational force, such as byincreasing the angle the support is positioned with respect to theground. In another instance, where component separation within thebiological sample droplet provides separated regions having insufficientenrichment (i.e., components of different density are not separated fromeach other to the extent desired), methods may include increasing theduration the biological sample droplet is subjected to the gravitationalforce or increasing the magnitude of the gravitational force, such as byincreasing the angle the support is positioned with respect to theground.

In some embodiments, where a single interval is not sufficient toprovide the desired extent of component separation within the biologicalsample droplet, methods may include conducting one or more additionalintervals. In these embodiments, protocols described herein forsubjecting a biological sample droplet to a gravitational force toseparate components of different density into two or more regions withinthe biological sample droplet are repeated one or more times in asequential manner. In practicing the subject methods, multiple intervalprotocols may include two or more intervals, such as three or moreintervals, such as four or more intervals, such as five or moreintervals, including ten or more intervals.

Aspects of the present disclosure also include dividing the biologicalsample into two or more product droplets. In practicing the subjectmethods, a droplet dividing force (e.g., mechanical agitation orelectric field) is applied for a duration sufficient to separate thebiological sample droplet into two or more separated product droplets.Each separated product droplet includes one or more of the regionshaving components of different density produced within the biologicalsample droplet as described above.

By “separated product droplets” is meant that product droplets preparedby the subject methods are not in fluid communication with each other.In other words, there is at least some void space between each productdroplet. In embodiments, depending on the protocol employed to dividethe biological sample droplet into product droplets, the distance formedbetween each product droplet may vary, where product droplets may beseparated by a distance of 0.001 mm or more, such as by 0.005 mm ormore, such as by 0.01 mm or more, such as by 0.05 mm or more, such as0.1 mm or more, such as by 0.5 mm or more, such as by 1 mm or more, suchas by 5 mm or more and including by 10 mm or more.

When separated, each product droplet may include one or more componentsof interest from the biological sample droplet, such as two or morecomponents of interest, such as three or more components of interest,such as 4 or more components of interest and including 5 or morecomponents of interest. For example, where the biological sample dropletincludes 4 components having different densities and is separated intotwo product droplets, a first product droplet may include 1 component ofinterest and the a second product droplet may include 3 components ofinterest. In other embodiments, a first product droplet may include 2components of interest and a second product droplet may include 2components of interest. In some instances, the biological sample dropletis whole blood and a first product droplet includes red blood cells anda second droplet includes white blood cells and plasma. In otherinstances, a first product droplet includes white blood cells and redblood cells and a second product droplet includes plasma.

In certain embodiments, the biological sample droplet is divided intomore than two separated droplets. For example, the biological sampledroplet may be separated into 3 or more droplets, such as 4 or moredroplets and including 5 or more droplets. In one instance, thebiological sample droplet includes 2 components of interest havingdifferent densities and the biological sample droplet is divided into 2product droplets, where each product droplet containing a component ofdifferent density. In other instances, the biological sample dropletincludes 3 components each having different densities and the biologicalsample droplet is divided into 3 product droplets, where each productdroplet containing a component of different density. In yet otherinstances, the biological sample droplet includes 4 components eachhaving different densities and the biological sample droplet is dividedinto 4 product droplets, where each product droplet containing acomponent of different density. In still other instances, the biologicalsample droplet includes 4 components of interest and the biologicalsample droplet is divided into 3 product droplets, where a first productdroplet includes two components, a second product droplet includes 1component and a third product droplet includes 1 component.

In some embodiments, the biological sample droplet is a biologicalsample containing cells and methods include dividing the biologicalsample droplet into two or more product droplets, where one or more ofthe product droplets contain cells and one or more of the productdroplets contain non-cellular components. In other embodiments, thebiological sample droplet contains two or more different types of cellsand methods include dividing the biological sample droplet into two ormore product droplets, where each product droplet includes a distincttype of cell. For example, in certain instances, the biological sampledroplet is whole blood and methods include dividing the biologicalsample droplet into a first product droplet containing red blood cellsand white blood cells and a second product droplet containing plasma. Inother embodiments, the biological sample droplet includes red bloodcells and white blood cells and method include dividing the biologicalsample droplet into a first product droplet containing red blood cellsand a second product droplet containing white blood cells.

Any convenient protocol may be employed to divide the biological sampledroplet into two or more product droplets, including but not limited tomechanical agitation, applying ultrasound, microfluidic protocols,applying a magnetic field and applying an electric field, among otherseparation protocols. In certain embodiments, the biological sampledroplet is divided into two or more product droplets by anelectrowetting protocol. The term “electrowetting” is used herein in itsconventional sense to refer to protocols for applying an electric fieldto the surface of the support through an array of electrodes to actuate,mix, agitate, dispense, split or transport fluidic droplets on thesurface of a support. For example, in some embodiments the support isconfigured with an array of electrodes to apply an electric field to thesupport and divide the biological sample droplet into two or moreproduct droplets.

By employing an electrowetting microactuation protocol, dividing thebiological sample droplet into product droplets can be controlled asdesired. In certain embodiments, the biological sample droplet ispositioned on top of one electrode while partially overlapping a secondelectrode on one side and third electrode on the opposite side.Activation of each electrode causes the biological sample droplet tospread across each of the three electrodes. Deactivation of the firstelectrode results in splitting of the biological sample droplet into twoproduct droplets a first product droplet positioned on top of the secondelectrode and a second product droplet positioned on top of the thirdelectrode.

In some embodiments, electrowetting protocols for dividing thebiological sample droplet into two or more product droplets may include,but are not limited to those described in U.S. Pat. Nos. 6,565,727;6,773,566; 6,911,132; 7,547,380; 7,329,545; 8,349,276; 8,470,153 and8,613,889, the disclosures of which are herein incorporated byreference.

In practicing the subject methods, one or more of the product dropletsmay be collected. In some embodiments, all of the separated productdroplets are collected. Collecting product droplets may includecombining the droplets together at a predetermined location on thesupport or the product droplets may be removed from the supportaltogether, as desired. In some embodiments, collecting product dropletsinclude combining the droplets together at a predetermined location onthe support, such as for example at a peripheral edge or at a corner ofthe support. In other embodiments, collecting product droplets includeremoving the droplets from the support and retaining the droplets in acollection reservoir.

Where more than one biological sample droplet (e.g., a plurality ofwhole blood droplets) is applied to the support, separated productdroplets having the same biological sample components may be collectedand combined together at a predetermined location on the support. Forexample, each of the plurality of biological sample droplets may bedivided into a first product droplet containing a first component, asecond product droplet containing a second component and a third productdroplet containing a third component. In this example, each of the firstproduct droplets may be combined together, each of the second productdroplets may be combined together or each of the third product dropletsmay be combined together.

Product droplets containing components of the biological sample may becollected at any time after dividing the biological sample droplet. Insome embodiments, the product droplets are collected 1 minute or greaterafter the separated droplets are prepared, such as 2 minutes or greater,such as 3 minutes or greater, such as 5 minutes or greater, such as 10minutes or greater and including 30 minutes or greater after dividingthe biological sample droplet.

In certain embodiments, product droplets are collected by conveying thedroplets across the support to a collection location along apredetermined path. In some instances, the conveyance path forcollecting the product droplets is along the perimeter of the support.In other instances, product droplets are collected and the conveyancepath is in line with each of the product droplets.

Any convenient protocol may be employed to convey and collect theproduct droplets along the support. In certain embodiments, productdroplets are conveyed and collected along the support surface by anelectrowetting protocol. As discussed above, “electrowetting” refers toprotocols for applying an electric field to the surface of the supportthrough an array of electrodes to move, mix, agitate, dispense, split ortransport fluidic droplets on the surface of a support. For example, insome embodiments the support is configured with an array of electrodesto move the separated droplets along predetermined paths across thesupport surface.

By employing an electrowetting microactuation protocol, movement bydroplets on the support can be controlled as desired. In certainembodiments, the subject droplet is positioned on top of one electrodewhile partially overlapping a second electrode. Activation of the firstand second electrode causes the droplet to spread a portion of thedroplet across the second electrode. Deactivation of the first electroderesults in movement of the droplet from the first electrode to thesecond electrode. In this embodiment, the second electrode is locatedadjacent to the first electrode along a first direction. To convey thedroplet across the support additional electrodes positioned in the firstdirection are sequentially activated and deactivated, resulting inmovement of the droplet along a predetermined path in the firstdirection. Additional directions for conveying the droplets as well asadditional paths along the support surface may be employed bycontrolling activation and deactivation of an array or network ofelectrodes, as desired.

Depending on the size of the support and droplets being moved, thenumber of electrode activation and deactivation cycles along apredetermined path may vary, such as 5 or more cycles, such as 10 ormore, such as 15 or more, such as 25 or more and including 50 or moreelectrode activation and deactivation cycles.

In some embodiments, the electrode array is configured to combinedroplets, such as at a collection location on the support. Droplets maybe combined together by moving the plurality of droplets (eithersequentially or simultaneously) to the same location on the support. Inthese embodiments, droplets may also be mixed. For example, in someinstances droplets may be conveyed to the same location and passivelymixed together by diffusion. In other instances, the combined dropletsare actively mixed, such as by agitating the combined droplets byvarying the frequency of the applied electric field at the collectionlocation. In certain embodiments, droplets are mixed by rotating thecombined droplets in a circular motion on the support by activating anddeactivating electrodes at the collection location in a circularpattern. Actuation by rotating the combined droplets in a circularpattern mixes the droplets by creating a turbulent non-reversible flowon the surface of the support as well as forming dispersedmultilaminates which enhance mixing of the droplets.

In some embodiments, electrowetting protocols for moving droplets alongthe surface of support of interest may include, but are not limited tothose described in U.S. Pat. Nos. 6,565,727; 6,773,566; 6,911,132;7,547,380; 7,329,545; 8,349,276; 8,470,153 and 8,613,889, thedisclosures of which are herein incorporated by reference.

In certain embodiments, methods further include assessing the collecteddroplets. For example, assessing the collected droplets may includedetermining the physical and chemical properties of the collecteddroplets. The physical and chemical properties of the collected dropletsmay be assessed with any convenient protocol, such as for example, byUV-vis spectrometry, IR spectroscopy, nuclear magnetic resonancespectroscopy, mass spectrometry, flame ionization spectrometry,high-performance liquid chromatography, among other analysis protocols.

In some instances, assessing the physical or chemical properties of thecollected droplets includes collecting real-time data, such as employinga detector (e.g., laser scatter detector, optical absorption detector,electrochemical sensor) at the collection location on the support. Inother instances, monitoring includes assessing the physical or chemicalproperties of the collected droplets at regular intervals, such as every0.01 minutes, every 0.05 minutes, every 0.1 minutes, every 0.5 minutes,every 1 minute, every 5 minutes, every 10 minutes, every 30 minutes,every 60 minutes or some other interval.

As discussed above, one or more of the product droplets may be collectedand removed from the support. In certain instances, one or more productdroplets may be left on the support (i.e., are not collected or removedfrom the support) and may be subjected to one or more additionalseparation intervals. In these embodiments, the subsequent separationintervals may include contacting product droplets of interest with washbuffer to produce a washed product droplet.

In some embodiments, the wash buffer is directly applied to the dropletsremaining on the surface of the support. In other embodiments, the washbuffer is applied to a peripheral position on the support and conveyedacross the support and combined with the subject droplets by anelectrowetting protocol.

Each of the subject droplets may be combined with the same or differentvolume of wash buffer. The volume of wash buffer combined with eachdroplet may vary, such as for example, ranging from 0.01 μL to 1000 μL,such as from 0.05 μL to 900 μL, such as from 0.1 μL to 800 μL, such asfrom 0.5 μL to 700 μL, such as from 1 μL to 600 μL, such as from 2.5 μLto 500 μL, such as from 5 μL to 400 μL, such as from 7.5 μL to 300 μLand including from 10 μL to 200 μL of wash buffer.

The wash buffer may be any suitable aqueous or organic liquid buffercomposition so long as the buffer is not deleterious or degrade thedesired components of the droplet. For example, wash buffers of interestmay include, but are not limited to, PBS (phosphate) buffer, acetatebuffer, N,N-bis(2-hydroxyethyl)glycine (Bicine) buffer,3-{[tris(hydroxymethyl)methyl]amino}propanesulfonic acid (TAPS) buffer,2-(N-morpholino)ethanesulfonic acid (MES) buffer, citrate buffer,tris(hydroxymethyl)methylamine (Tris) buffer,N-tris(hydroxymethyl)methylglycine (Tricine) buffer,3[N-Tris(hydroxymethypmethylamino]-2-hydroxypropanesulfonic Acid (TAPSO)buffer, 4-2-hydroxyethyl-1-piperazineethanesulfonic acid (HEPES) buffer,2-{[tris(hydroxymethyl)methyl]amino}ethanesulfonic acid (TES) buffer,piperazine-N,N′-bis(2-ethanesulfonic acid) (PIPES) buffer,dimethylarsinic acid (Cacodylate) buffer, saline sodium citrate (SSC)buffer, 2(R)-2-(methylamino)succinic acid (succinic acid) buffer,potassium phosphate buffer, N-Cyclohexyl-2-aminoethanesulfonic acid(CHES) buffer, among other types of wash buffer solutions.

In some embodiments, the washed droplets are then subjected to agravitational force and divided into two or more product droplets withan electrowetting protocol, such as described above. The washed dropletsmay be subjected to a gravitational force immediately after the subjectdroplets are combined with the wash buffer. In other embodiments, thewashed droplets are subjected to a gravitational force a predeterminedperiod of time after the subject droplets are combined with the washbuffer, such as for example, 0.01 minutes or more after the wash bufferis combined with the subject droplets, such as after 0.05 minutes ormore, such as after 0.1 minutes or more, such as after 0.5 minutes ormore, such as after 1 minute or more, such as after 5 minutes or more,such as after 10 minutes or more, such as after 15 minutes or more, suchas after 30 minutes or more and 60 or more.

FIG. 3 depicts a schematic showing the separation of an array ofbiological sample droplets on a support, where a first product dropletis removed from the support and a second product which is retained onthe support, is washed with a wash buffer droplet. At step 1, biologicalsample droplets 301 are contacted with support 300.

Subjecting the array of biological sample droplets to a gravitationalforce causes components which have a higher density to settle to thebottom region of the biological sample droplets while components havinga lower density remain in the upper region of the biological sampledroplets. Application of a droplet dividing force 310 b, such as anelectric field applied in an electrowetting protocol causes eachbiological sample droplet 301 to begin separating forming pre-separatedproduct droplets p303 which begins to divide the biological sampledroplet into two or more product droplets. After subjecting the array ofbiological sample droplets to dividing force 310 b (e.g., electricfield) for a sufficient duration, fully separated product droplets 303are formed from each of the pre-separated droplets p303 (step 3). Usingan electrowetting protocol, the remaining portion of biological sampledroplets 301 are removed from the support (step 4). Wash buffer droplets304 are contacted with the support and using an electrowetting protocol,wash buffer droplets 304 are combined with product droplets 303 to forman array of washed product droplets 305 (step 5). In certainembodiments, the above steps are repeated (step 6) on the washed productdroplets 305 (i.e., subjecting the droplets to a gravitational forcefollowed by dividing the droplets with a droplet dividing protocol) toform a second set of product droplets 306 from washed product droplets305, where product droplet 305 and product droplet 306 containcomponents of a biological sample droplet having different densities.

FIG. 4 depicts a schematic showing the separation of an array ofbiological sample columns on a support, where the remaining portion ofeach biological sample column is removed from the support and each ofthe separated droplets, which remain on the support, are washed with acolumn of wash buffer applied to the support. At step 1, biologicalsample columns 401 are contacted with support 400. Subjecting the arrayof biological sample columns to a gravitational force causes componentswhich have a higher density to settle to the bottom region of thebiological sample columns while components having a lower density remainin the upper region of the biological sample columns. At step 2, adividing force 410 b, such as an electric field applied in anelectrowetting protocol, causes each biological sample column 401 tobegin forming pre-separated product droplets p403 containing higherdensity components. After subjecting the array of biological samplecolumns to dividing force (e.g., electric field) 410 b for a sufficientduration, fully separated product droplets 403 are formed from each ofthe pre-separated droplets p403 (step 3). Using an electrowettingprotocol, the remaining portion of biological sample columns 401 areremoved from the support (step 4).

Columns of new wash buffer 404 are contacted with the support. Using anelectrowetting protocol, wash buffer columns 404 are combined withproduct droplets 403 to form an array of washed sample columns 405 (step5). In certain embodiments, the above steps are repeated (step 6) on thewashed sample columns 405 (i.e., subjecting the columns to agravitational force followed by separating out droplets from the columnswith a droplet dividing protocol) to form a second set of productdroplets 406 from washed sample columns 405, where product droplet 406contain components of a biological sample droplet having a differentdensity than components in product droplet 403.

Systems for Separating Components from a Biological Sample Droplet byGravity Sedimentation

Aspects of the present disclosure include systems for separatingcomponents of a biological sample droplet by subjecting the biologicalsample droplet to a gravitational force. As discussed above, by“separating components”, the subject systems isolate one or morecomponents of the biological sample droplet into distinct productdroplets and in some embodiments may be configured to separate cellsfrom other types of cells, separate cells from non-cellular debris(e.g., cell fragments, fragmented cell membranes, organelles, dead orlysed cells), separate cells from non-cellular macromolecules such asfree lipids, proteins, polysaccharides and nucleic acid fragments aswell as separate one type of non-cellular macromolecule from other typesnon-cellular macromolecules. In certain embodiments, the subject systemsare configured to separate components of whole blood, such as separatingwhite blood cells and red blood cells from plasma or separating whiteblood cells from red blood cells.

As summarized above, systems include a support configured to separate abiological sample droplet into two or more product droplets and anactuator for positioning the support in a manner sufficient to subjectthe biological sample droplets to a gravitational force.

In embodiments, the support is a solid support which can suitablyaccommodate one or more applied biological sample droplets. The supportmay be made of any suitable material so long as it does not degrade orhave any deleterious effects on the components of the biological sampleand biological sample droplets can be separated into two or more productdroplets. Suitable materials for supports may include, but are notlimited to glass, plastic or polymeric materials such as thermoplasticssuch as polycarbonates, polyesters (e.g., Mylar™ and polyethyleneterephthalate (PET)), polyvinyl chloride (PVC), polyurethanes,polyethers, polyamides, polyimides, or copolymers of thesethermoplastics, such as PETG (glycol-modified polyethyleneterephthalate). In some embodiments, the support is a dielectricmaterial, such as a vapor deposited dielectric, including parylene C(e.g., deposited on glass), parylene N; Teflon AF; Cytop, a filmdielectric including polyimide film (Kapton), fluorinated polymers suchas fluorinated ethylene propylene (FEP) includingperfluoroethylenepropylene copolymer, polytetrafluoroethylene (PTFE),perfluoralkoxy polymers and copolymers, cyclic olefin polymers andcopolymers as well as polyethylenes or may be a non-dielectric materialconfigured with a hydrophobic coating, such as Teflon AF, Cytop,Fluoropel coatings, silane coatings, fluorosilane coatings among othertypes of materials. The dielectric constant of support materials ofinterest may vary, ranging from 2 to 100, such as from 3 to 90, such asfrom 4 to 80, such as from 5 to 70, such as from 6 to 60, such as from 8to 50 and including from 10 to 40.

The size of the support may vary, ranging in some instances from 0.25cm² to 1000 cm², such as 0.5 cm² to 750 cm², such as 0.75 cm² to 500cm², such as 1 cm² to 250 cm², and including 2.5 cm² to 100 cm². Thethickness of the support may also vary, ranging in some instances from0.1 mm to 10 mm, such as from 0.5 mm to 8 mm, such as from 0.75 mm to 6mm and including ranging from 1 mm to 5 mm. The support may be anydesired shape, such a circle, oval, half-circle, crescent-shaped,star-shaped, square, triangle, rhomboid, pentagon, hexagon, heptagon,octagon, rectangle or other suitable polygon.

Where desired, the support may be flexible or rigid. The term “flexible”is used in its conventional sense to mean that the support is a planarsupport that is capable of being bent without breaking or otherwise ableto be turned, bowed, or twisted, without breaking. In these embodiments,the support may be pliable and is not rigid or stiff. In otherembodiments, the support is rigid. The term “rigid” is used in itsconventional sense to mean that the support is a planar support which isstiff and not capable of substantially being bent without breaking.

In some embodiments, systems of interest include a support coupled withone or more electrodes configured to apply an electric field (such as inan electrowetting protocol) to divide the biological sample droplet intotwo or more product droplets, as described above. In addition, thesupport may include one or more electrodes configured to apply anelectric field to move droplets on the surface of the support. Incertain embodiments, systems may include an array or network ofelectrodes coupled to the support. For example, systems of interest mayinclude supports coupled to an array of electrode having 2 electrodes ormore, such as 5 electrodes or more, such as 10 electrodes or more, suchas 15 electrodes or more, such as 25 electrodes or more and including anarray having 50 electrodes or more.

The array of electrodes may further include electrical connections forelectrically coupling electrodes to external circuitry. The array ofelectrodes may also include electrical connections for electricallycoupling certain electrodes together. In one example, the supportincludes two or more electrodes associated with the support, andincludes a source of electricity for activating and deactivating eachelectrode. For instance, each electrode may be electronically coupled toand controlled by a set of manual switches or a computer-controlledprocessor coupled to electronic circuitry for activating anddeactivating each electrode.

In some embodiments, systems are configured to supply a voltage to theelectrodes. Depending on the thickness and dielectric constant of thesupport, systems may be configured to apply a voltage to the electrodesin a range from 0.001 V to 1000 V, such as from 0.005 V to 750 V, suchas from 0.01 V to 500 V, such as from 0.05 V to 250 V, such as from 0.1V to 200 V and including from 1 V to 100 V.

In certain embodiments, systems of interest include electrode arrays andaccompanying electronic circuitry for manipulating droplets (moving,dividing, etc.) on the surface of a support such as those described inU.S. Pat. Nos. 6,565,727; 6,773,566; 6,911,132; 7,547,380; 7,329,545;8,349,276; 8,470,153 and 8,613,889, the disclosures of which are hereinincorporated by reference.

In certain embodiments, the support is configured as an array ofdiscrete regions. The discrete regions may have a random or non-randompattern, including patterns of specific shapes (circle, square, triangleor other polygon), letter or number configurations or imageconfigurations. In certain instances, the support has a grid pattern ofdiscrete regions. For example, the grid pattern may be composed ofequally sized squares or rectangles.

Each discrete location on the support may be the same or different size,as desired and may range from 0.01 to 5 cm², such as 0.05 to 5 cm², suchas 0.1 to 4.5 cm², such as 0.25 to 4.5 cm², such as 0.5 to 4 cm² andincluding 1 to 4 cm². Each discrete region may also have the same ordifferent physical properties from each other, such as size, electricalconductivity, surface wettability, etc. Where the subject systemsinclude an array or network of electrodes (as described above), eachdiscrete region may include one or more electrodes, such as two or moreelectrodes and including three or more electrodes in each discreteregion.

In some embodiments, each discrete region includes one or more sensors.In these embodiments, the sensors may be configured for determining thepresence of a fluidic droplet in the discrete region. In otherembodiments, sensors of interest may be configured for determining oneor more physical or chemical properties of the droplet positioned in thediscrete region. Sensor protocols of interest may include, but notlimited to laser scatter detectors, optical absorption detectors,electrochemical sensors, voltage sensors, among other types of sensors.

As summarized above, systems also include an actuator for positioningthe support in a manner sufficient to subject droplets on the support toa gravitational force. As discussed above, subjecting the biologicalsample droplet to a gravitational force, according to certainembodiments, includes positioning and maintaining the support at anangle with respect to a plane parallel to the surface of the ground suchthat gravity exerted by the Earth separates components of differentdensity into two or more regions within the biological sample droplet.In embodiments, the actuator is configured to position the support at anangle with respect to a plane parallel to the ground. The actuator maybe configured to position and maintain the support at any desired angle,such as at an angle that is 5° or greater with respect to a planeparallel to the surface of the ground, such as at an angle that is 10°or greater, such as at an angle that is 15° or greater, such as at anangle that is 25° or greater, such as at an angle that is 35° orgreater, such as at an angle that is 45° or greater, such as at an anglethat is 60° or greater, such as at an angle that is 75° or greater, suchas at an angle that is 80° or greater and including maintaining thesupport at an angle that is 90° with respect to a plane parallel to thesurface of the ground. In certain embodiments, the actuator isconfigured to position and maintain the support at an angle that is 45°or greater with respect to a plane parallel to the surface of theground. In other embodiments, the actuator is configured to position andmaintain the support at an angle that is 90° with respect to a planeparallel to the surface of the ground (i.e., directly in line with thedirection of the gravitational force) In other instances, the actuatoris configured to position and maintain the support ranging from 5° to90° with respect to a plane parallel to the surface of the ground, suchas at angle from 10° to 85°, such as from 15° to 80°, such as from 20°to 75°, such as from 25° to 70°, such as from 35° to 65° and including40° to 60° with respect to a plane parallel to the surface of theground.

Any actuation protocol may be employed to position the support at thedesired angle. In some embodiments, the support may be coupled to aplatform with a hinge or latch at a proximal edge of the support wherethe actuator positions the support at an angle by raising the distaledge of the support. In other embodiments, the actuator may be a liftcolumn that is coupled to the bottom of the support and positioning ofthe support by the actuator at an angle includes adjusting a pivot orrocker.

In some instances, actuation of the support to the desired angle iscarried out manually (i.e., positioning of the support by hand). Inother instances, the actuator is a mechanical actuation device, such asfor example a mechanical leadscrew assembly or a mechanically operatedgeared translation device. In yet other embodiments, the actuator is amotor-driven displacement device, such as a motor actuated displacementstage, motor driven leadscrew assembly, motor-operated geared actuationdevice employing a stepper motor, servo motor, brushless electric motor,brushed DC motor, micro-step drive motor, high resolution stepper motor,among other types of motors.

In certain embodiments, the actuator is computer controlled, wheresystems of interest may also include a processor operably coupled to theactuator, the processor having memory with instructions stored thereon,the instruction including algorithm for actuating the support andpositioning the support at a desired angle with respect to a planeparallel to the ground. Where the actuator is operably coupled to aprocessor for computer controlled actuation of the support, the subjectsystems may include both hardware and software components forcontrolling the actuator. For example, the hardware components may takethe form of one or more computers, servers, such that the functionalelements, i.e., those elements of the system that carry out specifictasks (such as managing input and output of information, processinginformation, etc.) of the system may be carried out by the execution ofsoftware applications on and across the one or more computer platformsrepresented of the system.

In these embodiments, systems may include a display and operator inputdevices, such as for example a keyboard, mouse, or the like forinputting desired parameters for actuating the support to the desiredposition. For example, parameters of interest may include the desiredangle for positioning the support, the duration the support ismaintained at the angle as well as any scheduled changes to thepositioning of the support.

The processor may include an operating system, a graphical userinterface (GUI) controller, a system memory, memory storage devices, andinput-output controllers, cache memory, a data backup unit, and manyother devices. The processor may be a commercially available processoror it may be one of other processors that are or will become available.The processor executes the operating system and the operating systeminterfaces with firmware and hardware in a well-known manner, andfacilitates the processor in coordinating and executing the functions ofvarious computer programs that may be written in a variety ofprogramming languages, such as Java, Perl, C++, other high level or lowlevel languages, as well as combinations thereof, as is known in theart. The operating system, typically in cooperation with the processor,coordinates and executes functions of the other components of thecomputer. The operating system also provides scheduling, input-outputcontrol, file and data management, memory management, and communicationcontrol and related services, all in accordance with known techniques.

The processor memory may be any of a variety of known or future memorystorage devices. Examples include any commonly available random accessmemory (RAM), magnetic medium such as a resident hard disk or tape, anoptical medium such as a read and write compact disc, flash memorydevices, or other memory storage device. The memory storage device maybe any of a variety of known or future devices, including a compact diskdrive, a tape drive, a removable hard disk drive, or a diskette drive.Such types of memory storage devices typically read from, and/or writeto, a program storage medium (not shown) such as, respectively, acompact disk, magnetic tape, removable hard disk, or floppy diskette.Any of these program storage media, or others now in use or that maylater be developed, may be considered a computer program product. Aswill be appreciated, these program storage media typically store acomputer software program and/or data. Computer software programs, alsocalled computer control logic, typically are stored in system memoryand/or the program storage device used in conjunction with the memorystorage device.

Memory may be any suitable device in which the processor can store andretrieve data, such as magnetic, optical, or solid state storage devices(including magnetic or optical disks or tape or RAM, flash drive, or anyother suitable device, either fixed or portable). The processor mayinclude a general purpose digital microprocessor suitably programmedfrom a computer readable medium carrying necessary program code.Programming can be provided remotely to processor through acommunication channel, or previously saved in a computer program productsuch as memory or some other portable or fixed computer readable storagemedium using any of those devices in connection with memory. Forexample, a magnetic or optical disk may carry the programming, and canbe read by a disk writer/reader. Systems of the invention also includeprogramming, e.g., in the form of computer program products, algorithmsfor use in practicing the methods as described above. Programmingaccording to the present invention can be recorded on computer readablemedia, e.g., any medium that can be read and accessed directly by acomputer. Such media include, but are not limited to: magnetic storagemedia, such as floppy discs, hard disc storage medium, and magnetictape; optical storage media such as CD-ROM; electrical storage mediasuch as RAM and ROM; portable flash drive; and hybrids of thesecategories such as magnetic/optical storage media.

The processor may also have access to a communication channel tocommunicate with a user at a remote location. By remote location ismeant the user is not directly in contact with the system and relaysinput information to an input manager from an external device, such as aa computer connected to a Wide Area Network (“WAN”), telephone network,satellite network, or any other suitable communication channel,including a mobile telephone (i.e., smartphone).

In some embodiments, systems according to the present disclosure may beconfigured to include a communication interface. In some embodiments,the communication interface includes a receiver and/or transmitter forcommunicating with a network and/or another device. The communicationinterface can be configured for wired or wireless communication,including, but not limited to, radio frequency (RF) communication (e.g.,Radio-Frequency Identification (RFID), Zigbee communication protocols,WiFi, infrared, wireless Universal Serial Bus (USB), Ultra Wide Band(UWB), Bluetooth® communication protocols, and cellular communication,such as code division multiple access (CDMA) or Global System for Mobilecommunications (GSM).

In some embodiments, systems may further include a biological samplestorage reservoir configured to dispense one or more biological sampledroplets to the support. The biological sample storage reservoir may beany suitable reservoir that is capable of storing and dispensingbiological sample to the support. The biological sample storagereservoir may be in fluid communication with the support and may beconfigured to provide 1 or more different types biological sampledroplets, such 2 or more different types of biological sample droplets,such as 3 or more different types of biological sample droplets, such as5 or more different types of biological sample droplets and including 10or more different types of biological sample droplets. Depending on theparticular design of the biological sample storage reservoir, systemsmay further include one or more inlets for delivering the biologicalsample to the support. In certain embodiments, systems of interestinclude one or more reservoirs in fluid communication with anelectrowetting microactuator configured to dispense a biological sampledroplet to a peripheral edge of the support and move the biologicalsample droplet to the desired location on the support.

Systems of the present disclosure may also include a wash buffer storagechamber configured to deliver one or more wash buffer droplets orcolumns of wash buffer to the support. The wash buffer storage chambermay be any suitable solvent reservoir that is capable of storing andproviding one or more wash buffers to the support to combine with theone or more droplets prepared on the support. The wash buffer chambermay be in fluid communication with one or more sources of wash bufferand may be a single high throughput storage reservoir which can providewash buffer as desired for contacting with droplets on the support. Asdiscussed above, systems may include a wash buffer that is an aqueous ororganic liquid buffer composition which is not deleterious or will notdegrade the desired components of the biological sample droplet. Forexample, wash buffers of interest may include, but are not limited to,PBS (phosphate) buffer, acetate buffer, N,N-bis(2-hydroxyethyl)glycine(Bicine) buffer, 3-{[tris(hydroxymethyl)methyl]amino}propanesulfonicacid (TAPS) buffer, 2-(N-morpholino)ethanesulfonic acid (MES) buffer,citrate buffer, tris(hydroxymethyl)methylamine (Tris) buffer,N-tris(hydroxymethyl)methylglycine (Tricine) buffer,3[N-Tris(hydroxymethypmethylamino]-2-hydroxypropanesulfonic Acid (TAPSO)buffer, 4-2-hydroxyethyl-1-piperazineethanesulfonic acid (HEPES) buffer,2-{[tris(hydroxymethyl)methyl]amino}ethanesulfonic acid (TES) buffer,piperazine-N,N′-bis(2-ethanesulfonic acid) (PIPES) buffer,dimethylarsinic acid (Cacodylate) buffer, saline sodium citrate (SSC)buffer, 2(R)-2-(methylamino)succinic acid (succinic acid) buffer,potassium phosphate buffer, N-Cyclohexyl-2-aminoethanesulfonic acid(CHES) buffer, among other types of wash buffer solutions.

The source of one or more wash buffers may be a reservoir withpre-measured aliquots for contacting with a predetermined number ofdroplets. For example, source of one or more wash buffers may includereservoirs which have pre-measured aliquots for contacting with 2droplets or more, such as 3 droplets or more, such as 5 droplets ormore, such as 10 droplets or more, such 25 droplets or more, such as 50droplets or more and including pre-measured aliquots for contacting with100 droplets or more. The one or more sources may include a single typeof wash buffer or may be capable of providing a plurality of differenttypes of wash buffers as desired. For example, the source may be capableof storing and providing, as desired, 2 different types of wash buffersor more, such as 3 different types of wash buffers or more, such as 5different types of wash buffers or more, and including 10 differenttypes of wash buffers or more. Depending on the particular design of thewash buffer chamber, the chamber may further include one or more inletsfor delivering the wash buffer to the support to contact with thesupport. In certain embodiments, systems of interest include one or morereservoirs in fluid communication with an electrowetting microactuatorconfigured to dispense wash buffer at a peripheral edge of the supportand move the wash buffer droplets to the desired location on thesupport.

Computer Controlled Systems

Aspects of the present disclosure may further include computercontrolled systems for practicing the subject methods, where the systemsfurther include one or more computers for automation or semi-automationof a system for practicing methods described herein. In embodiments,systems include a computer having a computer readable storage mediumwith a computer program stored thereon, where the computer program whenloaded on the computer includes algorithm for subjecting a biologicalsample droplet positioned on a support to a gravitational force;algorithm for dividing the biological sample droplet into two or moreproduct droplets and algorithm for collecting one or more of theseparated droplets. In certain embodiments, the computer program mayalso include algorithm for providing a biological sample droplet from abiological sample source to the surface of a support. For example, wherethe biological sample droplet is applied to the support by anelectrowetting microactuation protocol, the computer processor may alsoinclude algorithm for moving the contacted biological sample droplet toa desired location on the support.

In embodiments, the computer controlled system includes an input moduleand a processing module. In some embodiments, the subject systems mayinclude an input module such that parameters or information about eachbiological sample (type of sample, viscosity of fluid, droplet size,number of droplets), components from the biological sample that are ofinterest, the positioning angle for subjecting the biological sample toa gravitational force, the temperature of the support, agitationfrequency, information about the wash buffer and number of separationintervals, etc. may be inputted into the computer. The processing moduleincludes memory having a plurality of instructions for performingcertain steps of the subject methods, such as actuating a support toposition and maintain the support at an angle sufficient to subject thebiological sample droplet to a gravitational force as well asinstructions for dispensing and collecting the separated droplets. Inaddition, the processing module may include memory having a plurality ofinstructions for applying a droplet dividing force, such as an electricfield in an electrowetting protocol, in a manner sufficient to dividethe biological sample droplet into two or more product droplets.

The subject systems may include both hardware and software components,where the hardware components may take the form of one or moreplatforms, e.g., in the form of servers, such that the functionalelements, i.e., those elements of the system that carry out specifictasks (such as managing input and output of information, processinginformation, etc.) of the system may be carried out by the execution ofsoftware applications on and across the one or more computer platformsrepresented of the system.

Computer systems of interest may include a display and operator inputdevice. Operator input devices may, for example, be a keyboard, mouse,or the like. The processing module may include an operating system, agraphical user interface (GUI) controller, a system memory, memorystorage devices, and input-output controllers, cache memory, a databackup unit, and many other devices. The processor may be a commerciallyavailable processor or it may be one of other processors that are orwill become available. The processor executes the operating system andthe operating system interfaces with firmware and hardware in awell-known manner, and facilitates the processor in coordinating andexecuting the functions of various computer programs that may be writtenin a variety of programming languages, such as Java, Perl, C++, otherhigh level or low level languages, as well as combinations thereof, asis known in the art. The operating system, typically in cooperation withthe processor, coordinates and executes functions of the othercomponents of the computer. The operating system also providesscheduling, input-output control, file and data management, memorymanagement, and communication control and related services, all inaccordance with known techniques.

The system memory may be any of a variety of known or future memorystorage devices. Examples include any commonly available random accessmemory (RAM), magnetic medium such as a resident hard disk or tape, anoptical medium such as a read and write compact disc, flash memorydevices, or other memory storage device. The memory storage device maybe any of a variety of known or future devices, including a compact diskdrive, a tape drive, a removable hard disk drive, or a diskette drive.Such types of memory storage devices typically read from, and/or writeto, a program storage medium (not shown) such as, respectively, acompact disk, magnetic tape, removable hard disk, or floppy diskette.Any of these program storage media, or others now in use or that maylater be developed, may be considered a computer program product. Aswill be appreciated, these program storage media typically store acomputer software program and/or data. Computer software programs, alsocalled computer control logic, typically are stored in system memoryand/or the program storage device used in conjunction with the memorystorage device.

In some embodiments, a computer program product is described comprisinga computer usable medium having control logic (computer softwareprogram, including program code) stored therein. The control logic, whenexecuted by the processor the computer, causes the processor to performfunctions described herein. In other embodiments, some functions areimplemented primarily in hardware using, for example, a hardware statemachine. Implementation of the hardware state machine so as to performthe functions described herein will be apparent to those skilled in therelevant arts.

Memory may be any suitable device in which the processor can store andretrieve data, such as magnetic, optical, or solid state storage devices(including magnetic or optical disks or tape or RAM, or any othersuitable device, either fixed or portable). The processor may include ageneral purpose digital microprocessor suitably programmed from acomputer readable medium carrying necessary program code. Programmingcan be provided remotely to processor through a communication channel,or previously saved in a computer program product such as memory or someother portable or fixed computer readable storage medium using any ofthose devices in connection with memory. For example, a magnetic oroptical disk may carry the programming, and can be read by a diskwriter/reader. Systems of the invention also include programming, e.g.,in the form of computer program products, algorithms for use inpracticing the methods as described above. Programming according to thepresent invention can be recorded on computer readable media, e.g., anymedium that can be read and accessed directly by a computer. Such mediainclude, but are not limited to: magnetic storage media, such as floppydiscs, hard disc storage medium, and magnetic tape; optical storagemedia such as CD-ROM; electrical storage media such as RAM and ROM;portable flash drive; and hybrids of these categories such asmagnetic/optical storage media.

The processor may also have access to a communication channel tocommunicate with a user at a remote location. By remote location ismeant the user is not directly in contact with the system and relaysinput information to an input manager from an external device, such as acomputer connected to a Wide Area Network (“WAN”), telephone network,satellite network, or any other suitable communication channel,including a mobile telephone (i.e., smartphone).

Output controllers may include controllers for any of a variety of knowndisplay devices for presenting information to a user, whether a human ora machine, whether local or remote. If one of the display devicesprovides visual information, this information typically may be logicallyand/or physically organized as an array of picture elements. A graphicaluser interface (GUI) controller may include any of a variety of known orfuture software programs for providing graphical input and outputinterfaces between the system and a user, and for processing userinputs. The functional elements of the computer may communicate witheach other via system bus. Some of these communications may beaccomplished in alternative embodiments using network or other types ofremote communications. The output manager may also provide informationgenerated by the processing module to a user at a remote location, e.g.,over the Internet, phone or satellite network, in accordance with knowntechniques. The presentation of data by the output manager may beimplemented in accordance with a variety of known techniques. As someexamples, data may include SQL, HTML or XML documents, email or otherfiles, or data in other forms. The data may include Internet URLaddresses so that a user may retrieve additional SQL, HTML, XML, orother documents or data from remote sources. The one or more platformspresent in the subject systems may be any type of known computerplatform or a type to be developed in the future, although theytypically will be of a class of computer commonly referred to asservers. However, they may also be a main-frame computer, a workstation, or other computer type. They may be connected via any known orfuture type of cabling or other communication system including wirelesssystems, either networked or otherwise. They may be co-located or theymay be physically separated. Various operating systems may be employedon any of the computer platforms, possibly depending on the type and/ormake of computer platform chosen. Appropriate operating systems includeWindows NT®, Windows XP, Windows 7, Windows 8, iOS, Sun Solaris, Linux,OS/400, Compaq Tru64 Unix, SGI IRIX, Siemens Reliant Unix, and others.

Utility

The subject supports, systems, methods and computer systems find use ina variety of applications where it is desirable to separate componentsof a sample in a fluid medium. In some embodiments, the presentdisclosure finds use in preparing purified components of a biologicalsample such a whole blood sample where it is desirable to obtainisolated components of blood (e.g., white blood cells, red blood cells,platelets, plasma, etc.) Embodiments of the present disclosure also finduse in miniaturized sample preparation where only small quantities ofsample are available or where minimizing sample loss during enrichmentof a biological sample component is important.

The present disclosure finds use in applications where components (e.g.,cells or non-cellular macromolecules such as proteins andpolysaccharides) prepared from a biological sample may be desired forresearch, laboratory testing or for use in therapy. In some embodiments,the subject methods and systems may facilitate obtaining individualcells prepared from a target fluidic or tissue biological sample. Forexample, the subject methods and systems facilitate obtaining cells fromfluidic or tissue samples to be used as a research or diagnosticspecimen for diseases such as cancer. Likewise, the subject methods andsystems facilitate obtaining cells from fluidic or tissue samples to beused in therapy. Methods and devices of the present disclosure allow forseparating and collecting cells from a biological sample (e.g., organ,tissue, tissue fragment, fluid) with enhanced efficiency and low cost.

Kits

Aspects of the invention further include kits, where kits include one ormore supports as described herein. In some instances, the kits caninclude one or more separation protocol components (e.g., buffers) suchas described above. In some instances, the kits may further include asample collection device, e.g., a lance or needle configured to prickskin to obtain a whole blood sample, a pipette, etc., as desired.

The various assay components of the kits may be present in separatecontainers, or some or all of them may be pre-combined. For example, insome instances, one or more components of the kit, e.g., the supports,are present in a sealed pouch, e.g., a sterile foil pouch or envelope.

In addition to the above components, the subject kits may furtherinclude (in certain embodiments) instructions for practicing the subjectmethods. These instructions may be present in the subject kits in avariety of forms, one or more of which may be present in the kit. Oneform in which these instructions may be present is as printedinformation on a suitable medium or substrate, e.g., a piece or piecesof paper on which the information is printed, in the packaging of thekit, in a package insert, and the like. Yet another form of theseinstructions is a computer readable medium, e.g., diskette, compact disk(CD), portable flash drive, and the like, on which the information hasbeen recorded. Yet another form of these instructions that may bepresent is a website address which may be used via the internet toaccess the information at a removed site.

Notwithstanding the appended clauses, the disclosure set forth herein isalso defined by the following clauses:

1. A method comprising:

contacting a surface of a support with a biological sample droplet,wherein the biological sample droplet comprises components of differentdensities;

subjecting the biological sample droplet to a gravitational force toproduce two or more regions in the biological sample droplet, whereineach region in the biological sample droplet comprises a component fromthe biological sample having a different density;

separating the biological sample droplet into two or more productdroplets, wherein each product droplet comprises a different region ofthe biological sample droplet; and

collecting one or more of the separated product droplets.

2. The method according to clause 1, wherein subjecting the biologicalsample droplet to a gravitational force comprises maintaining thesupport in a vertical position sufficient to produce the two or moreregions in the biological sample droplet on the support surface bygravity sedimentation.3. The method according to clause 2, wherein subjecting the biologicalsample droplet to a gravitational force comprises maintaining thesupport at an angle that is 45 degrees or greater with respect to aplane parallel to the ground.4. The method according to clause 2, wherein subjecting the biologicalsample droplet to a gravitational force comprises maintaining thesupport at an angle that is 90 degrees with respect to a plane parallelto the ground.5. The method according to any one of clauses 1-4, wherein thebiological sample droplet occupies a discrete position on the support.6. The method according to clause 5, wherein the discrete positioncomprises an electrode configured to apply an electric field to thesupport at the discrete position.7. The method according to clause 6, wherein the electric field issufficient to divide the biological sample droplet into two or moreseparated product droplets comprising components of different densities.8. The method according to clause 7, wherein the method furthercomprises applying an electric field to the support in a mannersufficient to move one or more of the separated product droplets alongthe surface of the support.9. The method according to clause 8, wherein the product droplet ismoved along a predetermined path on the surface of the support.10. The method according to clause 9, wherein a plurality of productdroplets are combined at a predetermined region of the support.11. The method according to any one of clauses 1-10, further comprisingcontacting one or more of the separated product droplets with a washbuffer droplet to produce a washed droplet.12. The method according to clause 11, wherein the wash buffer dropletis contacted with a peripheral edge of the support and moved across thesupport.13. The method according to clause 11, wherein the wash buffer dropletis directly contacted with one or more of the separated productdroplets.14. The method according to clause 11, wherein the wash buffer dropletis mixed with one or more of the separated product droplets.15. The method according to clause 11, further comprising:

subjecting the washed droplet to a gravitational force sufficient toproduce two or more regions in the washed droplets, wherein each regionin the washed droplet comprises a component having a different density;

separating the washed droplet into two or more separated washed productdroplets, wherein each separated washed product droplet comprises adifferent region of the washed droplet; and

collecting one or more of the separated washed product droplets.

16. The method according to any one of clauses 1-15, wherein thebiological sample droplet is subjected to a gravitational force for 5minutes or longer.17. The method according to any one of clauses 1-15, wherein thebiological sample droplet is subjected to a gravitational force for 30minutes or longer.18. The method according to any one of clauses 1-15, wherein the methodcomprises contacting the biological sample droplet at a peripheral edgeof the support and moving the biological sample droplet to a discreteposition on the support.19. A method comprising:

contacting a surface of a support with a biological sample dropletcomprising a non-cellular component and a cellular component;

subjecting the biological sample droplet to a gravitational force toproduce two or more regions in the biological sample droplet, whereineach region in the biological sample droplet comprises a component fromthe biological sample having a different density;

dividing the biological sample droplet into two or more product dropletswherein each product droplet comprises a different region of thebiological sample droplet; and

collecting one or more of the separated product droplets.

20. The method according to clause 19, wherein the biological sampledroplet occupies a discrete position on the support.21. The method according to clause 20 wherein the discrete positioncomprises an electrode configured to apply an electric field to thesupport at the discrete position.22. The method according to clause 21, wherein the electric field issufficient to divide the biological sample droplet into two or moreseparated product droplets, wherein each product droplet comprises acellular component or non-cellular component of the biological sampledroplet.23. The method according to clause 22, wherein a first product dropletcomprises a cellular component and a second product droplet comprises anon-cellular component.24. The method according to clause 22, wherein a first product dropletcomprises two or more cellular components and a second product dropletcomprises a non-cellular component.25. The method according to clause 22, further comprising collecting thefirst product droplet.26. The method according to clause 22, further the second productdroplet.27. The method according to any one of clauses 19-26, wherein the methodfurther comprises applying an electric field to the support in a mannersufficient to move one or more of the separated product droplets alongthe surface of the support.28. The method according to clause 27, wherein the product droplet ismoved along a predetermined path along the surface of the support.29. The method according to clause 22, wherein the method comprisescollecting non-cellular component droplets.30. The method according to clause 29, wherein collecting non-cellularcomponent droplets comprises combining non-cellular component dropletstogether at predetermined location on the support31. The method according to clause 22, wherein the method comprisescollecting cellular component droplets.32. The method according to clause 31, wherein collecting cellularcomponent droplets comprises combining cellular component dropletstogether at predetermined location on the support.33. The method according to any one of clauses 19-32 wherein thebiological sample droplet is a whole blood droplet.34. The method according to clause 33, wherein the method comprisesseparating the biological sample droplet into a first product dropletcomprising red blood cells and white blood cells and a second productdroplet comprising plasma.35. The method according to clause 33, wherein the method comprisesseparating the biological sample droplet into a first product dropletcomprising plasma, a second product droplet comprising red blood cellsand a third product droplet comprising white blood cells.36. The method according to any one of clauses 19-35 wherein thebiological sample droplet is subjected to a gravitational force for 5minutes or longer.37. The method according to any one of clauses 19-35 wherein thebiological sample droplet is subjected to a gravitational force for 30minutes or longer.38. The method according to any one of clauses 19-37, wherein subjectingthe biological sample droplet to a gravitational force comprisesmaintaining the support at an angle that is 45 degrees or greater withrespect to a plane parallel to the ground.39. The method according to any one of clauses 19-38, wherein subjectingthe biological sample droplet to a gravitational force comprisesmaintaining the support at an angle that is 90 degrees with respect to aplane parallel to the ground.40. A system comprising:

a support configured to separate a biological sample droplet into two ormore distinct product droplets having different densities; and

an actuator for positioning the support at an angle with respect to aplane parallel to the ground sufficient to subject the biological sampleto a gravitational force.

41. The system according to clause 40, wherein the actuator isconfigured to position the support at an angle that is 45 degrees orgreater with respect to a plane parallel to the ground.42. The system according to clause 41, wherein the actuator isconfigured to position the support at an angle that is 90 degrees withrespect to a plane parallel to the ground.43. The system according to any one of clauses 40-42 further comprisinga processor operably coupled to the actuator, wherein the processorcomprises a memory with instructions thereon, the instructionscomprising an algorithm for positioning the support at an angle from 0degrees to 90 degrees with respect to a plane parallel to the ground.44. The system according to any one of clauses 40-43, wherein theactuator is coupled to the support at a peripheral edge of the support.45. The system according to any one of clauses 40-44, wherein theactuator is coupled to the support on a bottom surface of the support.46. The system according to any one of clauses 40-45, wherein thesurface of the support is divided into discrete regions.47. The system according to clause 46, wherein the support has a gridpattern of discrete regions.48. The system according to clause 47, wherein the grid patterncomprises 25 or more discrete regions.49. The system according to clause 47, wherein the support furthercomprises an array of electrodes beneath the support.50. The system according to clause 49, wherein each discrete regioncomprises an electrode.51. The system according to clause 49, wherein each discrete regioncomprises two or more electrodes.52. The system according to clause 49, wherein the array of electrodesis configured to apply an electric field to the support in a mannersufficient to divide a biological sample droplet into two or moreseparated product droplets on the support.53. The system according to clause 52, wherein the array of electrodesis configured to apply an electric field to the support in a mannersufficient to move one or more of the product droplets along the surfaceof the support.54. The system according to clause 53, wherein the array of electrodesis configured to apply an electric field to the support in a mannersufficient to move one or more of the product droplets to a peripheraledge of the surface of the support.55. The system according to clause 46, wherein each discrete regioncomprises a sensor.56. The system according to clause 55, wherein the sensor is anelectrochemical sensor.57. The system according to clause 55, wherein the sensor is an opticalsensor.58. The system according to clause 55, wherein the sensor is configuredto determine the presence of a fluidic sample in the discrete region.59. The system according to clause 58, wherein the system furthercomprises a processor comprising a memory operably coupled to theprocessor, wherein the memory includes instructions for determining thepresence of a fluidic sample at each discrete region.60. The system according to clause 55, wherein the sensor is configuredto determine one or more properties of the fluidic sample in thediscrete region.61. The system according to clause 60, wherein the system furthercomprises a processor comprising a memory operably coupled to theprocessor, wherein the memory includes instructions for determining oneor more properties of the fluidic sample at each discrete region.62. The system according to any one of clauses 40-61, wherein the systemfurther comprises a source of biological sample droplet.63. The system according to any one of clauses 40-62, wherein the systemfurther comprises a source of a wash buffer.64. A system for separating a biological fluid droplet into two or moredroplets comprising components having different densities, the systemcomprising:

a processor comprising a memory operably coupled to the processor,wherein the memory includes instructions stored thereon, theinstructions comprising:

-   -   instructions for contacting a biological sample droplet to a        surface of a support, wherein the biological sample comprises        components of different densities;    -   an algorithm for positioning the support at an angle from 0        degrees to 90 degrees with respect to a plane parallel to the        ground to subject the biological sample droplet to a        gravitational force sufficient to produce two or more regions in        the biological sample droplet, wherein each region in the        biological sample droplet comprises a component from the        biological sample having a different density;    -   an algorithm for applying a droplet dividing force to the        biological sample droplet in a manner sufficient to divide the        biological sample droplet into two or more product droplets,        wherein each product droplet comprises a different region of the        biological sample droplet; and    -   an algorithm for collecting one or more of the separated        droplets.        65. The system according to clause 64, wherein the memory        further comprises instructions for contacting wash buffer with        one or more of the separated product droplets.

Although the foregoing invention has been described in some detail byway of illustration and example for purposes of clarity ofunderstanding, it is readily apparent to those of ordinary skill in theart in light of the teachings of this disclosure that certain changesand modifications may be made thereto without departing from the spiritor scope of the appended claims.

Accordingly, the preceding merely illustrates the principles of theinvention. It will be appreciated that those skilled in the art will beable to devise various arrangements which, although not explicitlydescribed or shown herein, embody the principles of the invention andare included within its spirit and scope. Furthermore, all examples andconditional language recited herein are principally intended to aid thereader in understanding the principles of the invention being withoutlimitation to such specifically recited examples and conditions.Moreover, all statements herein reciting principles, aspects, andembodiments of the invention as well as specific examples thereof, areintended to encompass both structural and functional equivalentsthereof. Additionally, it is intended that such equivalents include bothcurrently known equivalents and equivalents developed in the future,i.e., any elements developed that perform the same function, regardlessof structure. The scope of the present invention, therefore, is notintended to be limited to the exemplary embodiments shown and describedherein. Rather, the scope and spirit of present invention is embodied bythe appended claims.

1. A method comprising: contacting a surface of a support with abiological sample droplet, wherein the biological sample dropletcomprises components of different densities; subjecting the biologicalsample droplet to a gravitational force to produce two or more regionsin the biological sample droplet, wherein each region in the biologicalsample droplet comprises a component from the biological sample having adifferent density; separating the biological sample droplet into two ormore product droplets, wherein each product droplet comprises adifferent region of the biological sample droplet; and collecting one ormore of the separated product droplets.
 2. The method according to claim1, wherein subjecting the biological sample droplet to a gravitationalforce comprises maintaining the support in a vertical positionsufficient to produce the two or more regions in the biological sampledroplet on the support surface by gravity sedimentation.
 3. The methodaccording to claim 1, wherein the method further comprises applying anelectric field to the support in a manner sufficient to: divide thebiological sample droplet into two or more separated product droplets,wherein each product droplet comprises a cellular component ornon-cellular component; and move one or more of the separated productdroplets along the surface of the support.
 4. The method according toclaim 3, wherein a first product droplet comprises two or more cellularcomponents and a second product droplet comprises a non-cellularcomponent.
 5. The method according to claim 3, wherein the biologicalsample droplet comprises whole blood and the method comprises separatingthe whole blood droplet into a first product droplet comprising plasma,a second product droplet comprising red blood cells and a third productdroplet comprising white blood cells.
 6. The method according to claim4, further comprising collecting one or more of the product droplets. 7.The method according to claim 4, wherein the method comprises collectingcellular component droplets.
 8. The method according to claim 7, whereinthe biological sample droplet comprises whole blood and the methodcomprises collecting droplets comprising red blood cells.
 9. The methodaccording to claim 7, wherein the biological sample droplet compriseswhole blood and the method comprises collecting droplets comprisingwhite blood cells.
 10. The method according to claim 3, furthercomprising: contacting one or more of the separated product dropletswith a wash buffer droplet to produce a washed droplet; subjecting thewashed droplet to a gravitational force sufficient to produce two ormore regions in the washed droplets, wherein each region in the washeddroplet comprises a component having a different density; separating thewashed droplet into two or more separated washed product droplets,wherein each separated washed product droplet comprises a differentregion of the washed droplet; and collecting one or more of theseparated washed product droplets.
 11. A system comprising: a supportconfigured to separate a biological sample droplet into two or moredistinct product droplets having different densities; and an actuatorfor positioning the support at an angle with respect to a plane parallelto the ground sufficient to subject the biological sample to agravitational force.
 12. The system according to claim 11, furthercomprising an array of electrodes beneath the support and configured toapply an electric field to the support in a manner sufficient to dividea biological sample droplet into two or more separated product dropletson the support and to move one or more of the product droplets along thesurface of the support.
 13. The system according to claim 11, whereinthe surface of the support is divided into discrete regions.
 14. Thesystem according to claim 13, wherein each discrete region comprises asensor configured to determine one or more of: the presence of a fluidicsample in the discrete region; and one or more properties of the fluidicsample in the discrete region.
 15. The system according to claim 13,wherein the system further comprises one or more of a source ofbiological sample droplet and a source of a wash buffer.
 16. A methodcomprising: contacting a surface of a support with a biological sampledroplet comprising a non-cellular component and a cellular component;subjecting the biological sample droplet to a gravitational force toproduce two or more regions in the biological sample droplet, whereineach region in the biological sample droplet comprises a component fromthe biological sample having a different density; dividing thebiological sample droplet into two or more product droplets wherein eachproduct droplet comprises a different region of the biological sampledroplet; and collecting one or more of the separated product droplets.17. The method according to claim 16, wherein the biological sampledroplet occupies a discrete position on the support.
 18. The methodaccording to claim 17, wherein the discrete position comprises anelectrode configured to apply an electric field to the support at thediscrete position.
 19. The method according to claim 18, wherein theelectric field is sufficient to divide the biological sample dropletinto two or more separated product droplets, wherein each productdroplet comprises a cellular component or non-cellular component of thebiological sample droplet.
 20. The method according to claim 19, furthercomprising collecting the first product droplet.